Track market-moving stories before they get noisy

Bank of Nova Scotia grew its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 16.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 886,454 shares of the company’s stock after buying an additional 124,651 shares during the period. Bank of Nova Scotia’s holdings in Johnson & Johnson were worth $225,132,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in Johnson & Johnson by 13.9% during the fourth quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock worth $7,502,000 after acquiring an additional 6,332 shares in the last quarter. United Bank grew its stake in shares of Johnson & Johnson by 110.7% in the 1st quarter. United Bank now owns 9,279 shares of the company’s stock valued at $1,539,000 after buying an additional 4,876 shares during the period. Sivia Capital Partners LLC increased its position in Johnson & Johnson by 13.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 5,863 shares of the company’s stock valued at $896,000 after buying an additional 692 shares in the last quarter. Wealth Group Ltd. increased its position in Johnson & Johnson by 12.8% in the 2nd quarter. Wealth Group Ltd. now owns 1,482 shares of the company’s stock valued at $226,000 after buying an additional 168 shares in the last quarter. Finally, Schnieders Capital Management LLC. raised its stake in Johnson & Johnson by 9.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 73,680 shares of the company’s stock worth $11,255,000 after buying an additional 6,584 shares during the period. 69.55% of the stock is owned by institutional investors and hedge funds.

Johnson & Johnson Trading Up 1.3% Shares of JNJ stock opened at $278.66 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.81 and a current ratio of 1.09. The company has a market capitalization of $671.54 billion, a price-to-earnings ratio of 32.29, a PEG ratio of 2.63 and a beta of 0.24. Johnson & Johnson has a 52-week low of $173.33 and a 52-week high of $281.07. The company has a 50-day simple moving average of $261.57 and a two-hundred day simple moving average of $244.85.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last announced its earnings results on Wednesday, July 15th. The company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.84 by $0.06. The firm had revenue of $25.31 billion for the quarter, compared to the consensus estimate of $25.06 billion. Johnson & Johnson had a return on equity of 32.42% and a net margin of 21.48%.The company’s revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.77 EPS. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. Research analysts anticipate that Johnson & Johnson will post 11.61 EPS for the current fiscal year. Johnson & Johnson Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 25th will be paid a $1.34 dividend. This represents a $5.36 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Tuesday, August 25th. Johnson & Johnson’s dividend payout ratio is 62.11%.

Key Headlines Impacting Johnson & Johnson Here are the key news stories impacting Johnson & Johnson this week:

Positive Sentiment: UBS initiated coverage with a Buy rating and a $320 price target, implying roughly 15%–16% upside from recent levels. The target reflects greater confidence in J&J’s pharmaceutical pipeline and potential for stronger growth. J&J Jumps as UBS Lifts Its Target to $320 Positive Sentiment: Recent business momentum remains constructive: J&J’s latest quarterly revenue increased 6.6% year over year, while earnings and revenue exceeded analyst expectations. A separate analysis noted that new products have more than offset sales lost from older medicines, supporting the company’s growth narrative. Johnson & Johnson Replaced Lost Sales With New Ones Neutral Sentiment: J&J will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. The presentation could provide updates on the pipeline, growth strategy and financial outlook, but the announcement itself does not change fundamentals. Johnson & Johnson to Participate in the Deutsche Bank Healthcare Summit Negative Sentiment: An analyst lowered the FY2026 EPS forecast, creating a modest headwind against the bullish analyst target and suggesting expectations for near-term earnings growth may be moderating. Negative Sentiment: Analysts continue to flag Stelara and upcoming drug patent expirations, weakness in MedTech and ongoing talc litigation as risks. The stock’s approximately 56% 12-month gain and valuation near its 52-week high leave less room for disappointment, particularly because the current price may already anticipate growth above management’s guidance. J&J Faces Multiple Headwinds Does J&J Talc Verdict Add to Legal Risk? Insiders Place Their Bets In other news, EVP Jennifer Taubert sold 15,000 shares of Johnson & Johnson stock in a transaction on Monday, August 17th. The stock was sold at an average price of $263.36, for a total transaction of $3,950,400.00. Following the sale, the executive vice president directly owned 194,451 shares in the company, valued at $51,210,615.36. The trade was a 7.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Kathryn Wengel sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $241.15, for a total transaction of $2,411,500.00. Following the completion of the transaction, the executive vice president directly owned 114,288 shares in the company, valued at $27,560,551.20. This trade represents a 8.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 63,972 shares of company stock valued at $16,245,605. 0.16% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades A number of brokerages have commented on JNJ. Weiss Ratings raised Johnson & Johnson from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, July 24th. Johnson Rice reaffirmed a “buy” rating on shares of Johnson & Johnson in a research report on Monday, August 3rd. Wall Street Zen downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Citigroup boosted their price target on shares of Johnson & Johnson from $285.00 to $298.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Finally, Bank of America upped their price objective on shares of Johnson & Johnson from $254.00 to $263.00 and gave the stock a “neutral” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $272.83.

View Our Latest Stock Report on Johnson & Johnson

Johnson & Johnson Profile (Free Report)

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.

Read More Five stocks we like better than Johnson & Johnson The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Clear Harbor Asset Management LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,875 shares of the company’s stock after selling 2,278 shares during the quarter. Johnson & Johnson accounts for 0.9% of Clear Harbor Asset Management LLC’s investment portfolio, making the stock its 22nd largest holding. Clear Harbor Asset Management LLC’s holdings in Johnson & Johnson were worth $14,699,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in JNJ. Blueline Advisors LLC acquired a new position in Johnson & Johnson during the 4th quarter worth approximately $25,000. Cresta Advisors Ltd. acquired a new stake in shares of Johnson & Johnson in the 4th quarter valued at approximately $26,000. Bay Harbor Wealth Management LLC boosted its stake in shares of Johnson & Johnson by 49.0% in the fourth quarter. Bay Harbor Wealth Management LLC now owns 149 shares of the company’s stock valued at $31,000 after buying an additional 49 shares in the last quarter. Semmax Financial Advisors Inc. grew its holdings in Johnson & Johnson by 55.0% during the second quarter. Semmax Financial Advisors Inc. now owns 203 shares of the company’s stock worth $31,000 after acquiring an additional 72 shares during the period. Finally, E Fund Management Hong Kong Co. Ltd. raised its position in Johnson & Johnson by 946.7% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 157 shares of the company’s stock worth $32,000 after acquiring an additional 142 shares in the last quarter. Hedge funds and other institutional investors own 69.55% of the company’s stock.

Johnson & Johnson Trading Up 1.3% Johnson & Johnson stock opened at $278.66 on Friday. The stock has a 50-day moving average price of $261.57 and a 200 day moving average price of $244.85. Johnson & Johnson has a 52 week low of $173.33 and a 52 week high of $281.07. The stock has a market cap of $671.54 billion, a PE ratio of 32.29, a P/E/G ratio of 2.63 and a beta of 0.24. The company has a current ratio of 1.09, a quick ratio of 0.81 and a debt-to-equity ratio of 0.44.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its quarterly earnings results on Wednesday, July 15th. The company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.84 by $0.06. The company had revenue of $25.31 billion for the quarter, compared to analysts’ expectations of $25.06 billion. Johnson & Johnson had a net margin of 21.48% and a return on equity of 32.42%. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the company earned $2.77 EPS. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. Equities research analysts predict that Johnson & Johnson will post 11.61 earnings per share for the current fiscal year. Johnson & Johnson Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 25th will be paid a $1.34 dividend. This represents a $5.36 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, August 25th. Johnson & Johnson’s payout ratio is presently 62.11%.

Analysts Set New Price Targets A number of analysts recently commented on JNJ shares. Wells Fargo & Company boosted their price objective on shares of Johnson & Johnson from $272.00 to $282.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. TD Cowen lifted their price target on shares of Johnson & Johnson from $250.00 to $300.00 and gave the company a “buy” rating in a research report on Monday, July 13th. Johnson Rice restated a “buy” rating on shares of Johnson & Johnson in a report on Monday, August 3rd. Weiss Ratings upgraded Johnson & Johnson from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, July 24th. Finally, Stifel Nicolaus set a $260.00 target price on Johnson & Johnson in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Johnson & Johnson currently has an average rating of “Moderate Buy” and an average target price of $272.83.

Read Our Latest Research Report on Johnson & Johnson

Insiders Place Their Bets In other news, EVP Elizabeth Forminard sold 15,918 shares of Johnson & Johnson stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $257.00, for a total value of $4,090,926.00. Following the completion of the sale, the executive vice president owned 16,994 shares of the company’s stock, valued at $4,367,458. The trade was a 48.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Jennifer L. Taubert sold 15,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $263.36, for a total value of $3,950,400.00. Following the transaction, the executive vice president owned 194,451 shares in the company, valued at $51,210,615.36. This trade represents a 7.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 63,972 shares of company stock valued at $16,245,605. Insiders own 0.16% of the company’s stock.

Key Johnson & Johnson News Here are the key news stories impacting Johnson & Johnson this week:

Positive Sentiment: UBS initiated coverage with a Buy rating and a $320 price target, implying roughly 15%–16% upside from recent levels. The target reflects greater confidence in J&J’s pharmaceutical pipeline and potential for stronger growth. J&J Jumps as UBS Lifts Its Target to $320 Positive Sentiment: Recent business momentum remains constructive: J&J’s latest quarterly revenue increased 6.6% year over year, while earnings and revenue exceeded analyst expectations. A separate analysis noted that new products have more than offset sales lost from older medicines, supporting the company’s growth narrative. Johnson & Johnson Replaced Lost Sales With New Ones Neutral Sentiment: J&J will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. The presentation could provide updates on the pipeline, growth strategy and financial outlook, but the announcement itself does not change fundamentals. Johnson & Johnson to Participate in the Deutsche Bank Healthcare Summit Negative Sentiment: An analyst lowered the FY2026 EPS forecast, creating a modest headwind against the bullish analyst target and suggesting expectations for near-term earnings growth may be moderating. Negative Sentiment: Analysts continue to flag Stelara and upcoming drug patent expirations, weakness in MedTech and ongoing talc litigation as risks. The stock’s approximately 56% 12-month gain and valuation near its 52-week high leave less room for disappointment, particularly because the current price may already anticipate growth above management’s guidance. J&J Faces Multiple Headwinds Does J&J Talc Verdict Add to Legal Risk? (Free Report)

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.

Read More Five stocks we like better than Johnson & Johnson The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Evolve Private Wealth LLC lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 27.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,341 shares of the company’s stock after selling 11,894 shares during the period. Johnson & Johnson makes up 0.5% of Evolve Private Wealth LLC’s portfolio, making the stock its 27th biggest position. Evolve Private Wealth LLC’s holdings in Johnson & Johnson were worth $7,960,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. World Investment Advisors grew its holdings in Johnson & Johnson by 19.6% during the fourth quarter. World Investment Advisors now owns 161,343 shares of the company’s stock worth $33,390,000 after purchasing an additional 26,450 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Johnson & Johnson by 0.8% during the 4th quarter. Principal Financial Group Inc. now owns 3,410,177 shares of the company’s stock worth $705,736,000 after acquiring an additional 28,370 shares during the period. Signal Advisors Wealth LLC increased its holdings in shares of Johnson & Johnson by 76.1% during the 1st quarter. Signal Advisors Wealth LLC now owns 15,126 shares of the company’s stock worth $3,697,000 after acquiring an additional 6,539 shares during the last quarter. Louisiana State Employees Retirement System bought a new stake in Johnson & Johnson in the 1st quarter valued at $30,017,000. Finally, Gradient Investments LLC lifted its holdings in Johnson & Johnson by 9.9% during the 2nd quarter. Gradient Investments LLC now owns 152,831 shares of the company’s stock valued at $38,815,000 after purchasing an additional 13,737 shares during the last quarter. Institutional investors own 69.55% of the company’s stock.

Insider Buying and Selling at Johnson & Johnson In other news, EVP Jennifer Taubert sold 15,000 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $263.36, for a total transaction of $3,950,400.00. Following the completion of the transaction, the executive vice president owned 194,451 shares of the company’s stock, valued at approximately $51,210,615.36. This trade represents a 7.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Kathryn Wengel sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $241.15, for a total value of $2,411,500.00. Following the transaction, the executive vice president owned 114,288 shares of the company’s stock, valued at $27,560,551.20. This trade represents a 8.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 63,972 shares of company stock valued at $16,245,605. 0.16% of the stock is owned by insiders.

Analyst Ratings Changes JNJ has been the topic of several research analyst reports. Freedom Capital raised shares of Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Wells Fargo & Company increased their price objective on Johnson & Johnson from $272.00 to $282.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Wall Street Zen lowered shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings raised shares of Johnson & Johnson from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, July 24th. Finally, TD Cowen raised their target price on shares of Johnson & Johnson from $250.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $272.83. Read Our Latest Analysis on JNJ

Key Johnson & Johnson News Here are the key news stories impacting Johnson & Johnson this week:

Positive Sentiment: UBS initiated coverage with a Buy rating and a $320 price target, implying roughly 15%–16% upside from recent levels. The target reflects greater confidence in J&J’s pharmaceutical pipeline and potential for stronger growth. J&J Jumps as UBS Lifts Its Target to $320 Positive Sentiment: Recent business momentum remains constructive: J&J’s latest quarterly revenue increased 6.6% year over year, while earnings and revenue exceeded analyst expectations. A separate analysis noted that new products have more than offset sales lost from older medicines, supporting the company’s growth narrative. Johnson & Johnson Replaced Lost Sales With New Ones Neutral Sentiment: J&J will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. The presentation could provide updates on the pipeline, growth strategy and financial outlook, but the announcement itself does not change fundamentals. Johnson & Johnson to Participate in the Deutsche Bank Healthcare Summit Negative Sentiment: An analyst lowered the FY2026 EPS forecast, creating a modest headwind against the bullish analyst target and suggesting expectations for near-term earnings growth may be moderating. Negative Sentiment: Analysts continue to flag Stelara and upcoming drug patent expirations, weakness in MedTech and ongoing talc litigation as risks. The stock’s approximately 56% 12-month gain and valuation near its 52-week high leave less room for disappointment, particularly because the current price may already anticipate growth above management’s guidance. J&J Faces Multiple Headwinds Does J&J Talc Verdict Add to Legal Risk? Johnson & Johnson Stock Performance NYSE JNJ opened at $278.66 on Friday. Johnson & Johnson has a 1 year low of $173.33 and a 1 year high of $281.07. The firm has a market capitalization of $671.54 billion, a price-to-earnings ratio of 32.29, a P/E/G ratio of 2.63 and a beta of 0.24. The company has a current ratio of 1.09, a quick ratio of 0.81 and a debt-to-equity ratio of 0.44. The firm’s 50 day simple moving average is $261.57 and its 200 day simple moving average is $244.85.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its earnings results on Wednesday, July 15th. The company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.84 by $0.06. Johnson & Johnson had a return on equity of 32.42% and a net margin of 21.48%.The firm had revenue of $25.31 billion during the quarter, compared to analysts’ expectations of $25.06 billion. During the same period in the prior year, the company earned $2.77 earnings per share. The company’s quarterly revenue was up 6.6% on a year-over-year basis. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. As a group, research analysts expect that Johnson & Johnson will post 11.61 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 25th will be given a dividend of $1.34 per share. The ex-dividend date is Tuesday, August 25th. This represents a $5.36 annualized dividend and a yield of 1.9%. Johnson & Johnson’s dividend payout ratio (DPR) is currently 62.11%.

Johnson & Johnson Company Profile (Free Report)

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.

Featured Articles Five stocks we like better than Johnson & Johnson The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Ford shareholders are collecting a 5.51% yield right now, but there is a reason income investors with long memories are watching this payout far more closely than the headline number suggests.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Ford’s latest quarterly check landed in shareholders’ accounts on September 1, 2026, and the payment was familiar: $0.15 per share, unchanged for the ninth straight regular quarter. Ford (NYSE:F | F Price Prediction) still carries a 5.51% yield that towers over the 4.75% 10-year Treasury, but income investors have long memories, and this payout has already been reset once.

A Prior Cut Still Hangs Over the Payout Ford slashed the regular dividend to $0.10 in early 2022 before restoring it to $0.15 that August. That reset means there is no consecutive-growth streak to lean on, and the base dividend has not risen in four years. Management has substituted supplemental payments instead: a $0.40625 special hit accounts in August, following supplementals of $0.30 in 2025 and $0.33 in 2024. Nice bonuses, but the recurring commitment stays flat.

Coverage Is Suddenly a Strength The near-term coverage math looks better than it did a year ago. Q2 2026 delivered reported EPS of $0.42 against the $0.15 payout, and Q1 2026 EPS came in at $0.66. Ford generated $2.1 billion in company adjusted free cash flow in Q2, ended the quarter with $22.3 billion in cash, and raised full-year adjusted free cash flow guidance to $6 billion to $7 billion. CFO Sherry House told investors, “We remain committed to our investment grade rating in returning capital as shareholders.”

Warning Lights Are Still Blinking FY2025 booked a net loss of $8.16 billion after impairments, and Ford paid out $2.99 billion in dividends against that loss. Model E is guided to lose about $4 billion in EBIT this year, and the trailing P/E sits at -7 with a debt-to-equity ratio of 4.66. The 76 basis-point yield premium over Treasuries is not a fat cushion for equity risk, and a prior cut plus a flat base payout are exactly the setup we flagged in a free report on the seven warning signs a big yield is about to be cut.

Grading The Dividend: C+ Yield beats the risk-free rate, current cash flow covers the payout comfortably, and management raised EBIT guidance to $10 billion to $11 billion. But zero growth in four years, a documented cut, EV losses, and cyclical exposure keep this scorecard capped. Shares have returned 26.4% over the past year, and Ford’s Super Duty production just hit a 20-year high, which helps the case. Income investors get paid to wait. They just should not confuse a flat dividend with a growing one.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →

Berkshire Capital Holdings Inc. bought a new position in shares of Intel Corporation (NASDAQ:INTC – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 160,840 shares of the chip maker’s stock, valued at approximately $22,458,000. Intel comprises 4.9% of Berkshire Capital Holdings Inc.’s holdings, making the stock its 10th biggest position.

Several other institutional investors also recently bought and sold shares of INTC. Sivia Capital Partners LLC grew its holdings in Intel by 271.7% during the second quarter. Sivia Capital Partners LLC now owns 34,201 shares of the chip maker’s stock valued at $766,000 after purchasing an additional 25,001 shares during the last quarter. United Bank acquired a new stake in shares of Intel in the second quarter worth $205,000. Gamco Investors INC. ET AL lifted its stake in shares of Intel by 12.3% in the second quarter. Gamco Investors INC. ET AL now owns 13,737 shares of the chip maker’s stock worth $308,000 after buying an additional 1,508 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Intel by 29.6% during the 2nd quarter. NewEdge Advisors LLC now owns 158,277 shares of the chip maker’s stock worth $3,545,000 after buying an additional 36,116 shares during the period. Finally, Sei Investments Co. boosted its holdings in shares of Intel by 9.9% during the 2nd quarter. Sei Investments Co. now owns 828,352 shares of the chip maker’s stock worth $18,556,000 after buying an additional 74,838 shares during the period. 64.53% of the stock is currently owned by institutional investors.

Insiders Place Their Bets In other news, CEO Lip Bu Tan bought 105,263 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was bought at an average price of $95.00 per share, for a total transaction of $9,999,985.00. Following the completion of the purchase, the chief executive officer owned 1,314,669 shares of the company’s stock, valued at approximately $124,893,555. The trade was a 8.70% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.05% of the company’s stock.

Trending Headlines about Intel Here are the key news stories impacting Intel this week: Positive Sentiment: A reported leak suggesting Intel could launch its Nova Lake client processor lineup as early as 2027 provided a potential catalyst. Earlier availability could strengthen Intel’s product roadmap and support a recovery in its PC and data-center businesses. Intel Stock Gains as Nova Lake Launch Schedule Leaks Positive Sentiment: Coverage highlighted Nvidia’s roughly $5 billion investment in Intel, including its purchase of more than 214 million shares at $23.28 each, and the companies’ product collaboration. The large paper gain on Nvidia’s stake reinforces market confidence in Intel’s strategic importance and AI potential, although it does not directly generate new revenue for Intel. Nvidia’s Intel Investment and Partnership Positive Sentiment: Intel’s expanded partnership with Kasm Technologies will run private large language models on Xeon 6 processors with Advanced Matrix Extensions, targeting regulated customers that require local and compliant AI. The deal supports Intel’s strategy of positioning Xeon as infrastructure for enterprise AI workloads. Intel Kasm AI Partnership Neutral Sentiment: Intel recently reported stronger-than-expected quarterly revenue and earnings, with revenue up 25% year over year, while management expects 2026 capital expenditures to exceed $20 billion and spending to rise significantly in 2027. The investment could support future manufacturing and AI growth, but it increases execution and cash-flow demands. Intel’s Five-Year Outlook Neutral Sentiment: A separate report said Intel’s 14A manufacturing process is beginning to demonstrate its strategic value, offering a potential long-term foundry catalyst. However, meaningful financial benefits depend on customer commitments and successful execution. Negative Sentiment: Mizuho analyst Vijay Rakesh cut his Intel price target to $92 from $109 while retaining a Hold rating, arguing that AI strength may not offset near-term business strain. The revised target leaves limited upside based on the referenced trading level. Mizuho Cuts Intel Price Target Negative Sentiment: Intel traded lower in premarket alongside Micron, SanDisk and AMD as semiconductor stocks faced broader sector pressure. Commentary also emphasized AMD’s stronger AI and data-center margin profile, highlighting competitive risks for Intel’s turnaround. Intel Price Performance NASDAQ:INTC opened at $91.67 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.25 and a current ratio of 1.60. The company has a 50-day moving average of $101.10 and a 200-day moving average of $87.85. The company has a market capitalization of $462.38 billion, a price-to-earnings ratio of -43.45, a PEG ratio of 9.94 and a beta of 2.22. Intel Corporation has a 52 week low of $23.75 and a 52 week high of $142.35.

Intel (NASDAQ:INTC – Get Free Report) last released its quarterly earnings data on Thursday, July 23rd. The chip maker reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.21. The company had revenue of $16.13 billion for the quarter, compared to analyst estimates of $14.43 billion. Intel had a positive return on equity of 2.62% and a negative net margin of 19.79%.The company’s revenue was up 25.2% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.10) EPS. Intel has set its Q3 2026 guidance at 0.380-0.380 EPS. As a group, equities research analysts anticipate that Intel Corporation will post 1.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades Several brokerages recently commented on INTC. Oppenheimer started coverage on shares of Intel in a report on Thursday, June 11th. They issued an “outperform” rating on the stock. Bank of America lowered their price target on Intel from $160.00 to $145.00 and set a “buy” rating on the stock in a research report on Wednesday, August 12th. Citigroup upgraded Intel from a “positive” rating to a “buy” rating in a research note on Thursday, July 23rd. Morgan Stanley boosted their price objective on Intel from $75.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, July 24th. Finally, Daiwa Securities Group downgraded Intel from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, thirty-one have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $107.46.

Check Out Our Latest Research Report on INTC

Intel Profile (Free Report)

Intel Corporation, founded in 1968 by Robert Noyce and Gordon E. Moore and headquartered in Santa Clara, California, is a leading global designer and manufacturer of semiconductor products. The company is historically notable for introducing the first commercial microprocessor and for driving the x86 architecture that underpins many personal computers and servers. Intel’s core business spans the design, fabrication and marketing of processors, chipsets and related components for a wide range of computing applications.

Intel’s product portfolio includes client and mobile processors marketed under brands such as Intel Core and Pentium, as well as high-performance Xeon processors for data centers and cloud infrastructure.

Read More Five stocks we like better than Intel The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.

Intel ( INTC ) stock is in focus after Mizuho analyst Vijay Rakesh lowered his price target to $92 from $109 while keeping a Hold view on the shares.

Rakesh said Intel could benefit from rising demand for processors used in artificial intelligence inference. He expects the balance between CPU and GPU workloads to improve over time as agentic AI expands, potentially supporting tighter CPU supply through 2027.

The analyst also sees a longer-term opportunity in Intel's manufacturing operations. He expects advanced packaging revenue to reach about $3.5 billion by 2029, with external foundry activity also potentially reaching that level as the company advances its 14A process.

Still, near-term profitability remains a concern. Rakesh pointed to pressure from new manufacturing nodes, weaker PC demand and a valuation that leaves limited room for disappointment.

TipRanks shows a Hold consensus, with 24 Holds, five Buys and two Sells. The average price target is $116.16, implying about 27% upside.

What it means for the stock: Intel may have AI-driven growth ahead, but investors still face execution and margin risks.

Diversify Advisory Services LLC bought a new stake in shares of International Business Machines Corporation (NYSE:IBM – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 52,800 shares of the technology company’s stock, valued at approximately $11,420,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. BlackRock Inc. bought a new stake in shares of International Business Machines during the second quarter valued at about $21,586,659,000. Bank of New York Mellon Corp bought a new position in International Business Machines in the 2nd quarter valued at about $2,606,782,000. Norges Bank bought a new position in International Business Machines in the 4th quarter valued at about $2,446,429,000. Capital World Investors increased its stake in International Business Machines by 29.2% during the 4th quarter. Capital World Investors now owns 22,021,912 shares of the technology company’s stock valued at $6,523,720,000 after buying an additional 4,976,756 shares during the period. Finally, Deutsche Bank AG acquired a new position in International Business Machines during the 2nd quarter valued at about $960,839,000. Institutional investors own 58.96% of the company’s stock.

Analysts Set New Price Targets A number of analysts have recently weighed in on IBM shares. Bank of America upped their price target on shares of International Business Machines from $315.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, July 6th. Royal Bank Of Canada reiterated an “outperform” rating and set a $270.00 price objective on shares of International Business Machines in a research note on Tuesday, July 21st. KeyCorp downgraded International Business Machines to a “sector weight” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. decreased their price target on International Business Machines from $291.00 to $250.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Finally, HSBC set a $175.00 price target on International Business Machines and gave the company a “reduce” rating in a research report on Thursday, July 16th. Sixteen analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $265.90.

Check Out Our Latest Stock Analysis on IBM Insider Buying and Selling at International Business Machines In related news, SVP Robert Thomas sold 25,000 shares of the stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $230.32, for a total value of $5,758,000.00. Following the completion of the transaction, the senior vice president owned 47,800 shares in the company, valued at $11,009,296. This trade represents a 34.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

International Business Machines Stock Performance Shares of IBM opened at $234.00 on Friday. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.79 and a quick ratio of 0.74. The firm’s 50 day moving average is $242.40 and its 200-day moving average is $247.21. International Business Machines Corporation has a 12-month low of $199.19 and a 12-month high of $332.46. The stock has a market capitalization of $220.46 billion, a P/E ratio of 20.76, a P/E/G ratio of 2.21 and a beta of 0.71.

International Business Machines (NYSE:IBM – Get Free Report) last released its earnings results on Wednesday, July 22nd. The technology company reported $2.93 EPS for the quarter, meeting the consensus estimate of $2.93. The business had revenue of $17.16 billion during the quarter, compared to analyst estimates of $17.46 billion. International Business Machines had a net margin of 15.52% and a return on equity of 35.65%. The business’s quarterly revenue was up 1.1% on a year-over-year basis. During the same period in the prior year, the business earned $2.80 earnings per share. Equities research analysts anticipate that International Business Machines Corporation will post 12.33 EPS for the current fiscal year.

International Business Machines Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 10th. Stockholders of record on Monday, August 10th will be given a dividend of $1.69 per share. This represents a $6.76 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, August 10th. International Business Machines’s dividend payout ratio is 59.98%.

Key Headlines Impacting International Business Machines Here are the key news stories impacting International Business Machines this week:

Positive Sentiment: Quantum-computing advances support IBM’s growth narrative. IBM reportedly achieved a 25-fold throughput improvement, reinforcing its position in quantum hardware and software and adding to investor enthusiasm around emerging technology opportunities. Quantum Computing News: IBM Hits 25x Throughput Gain, RGTI Shows Up to 100x Speedup Positive Sentiment: Valuation and shareholder returns are attracting buyers. One analysis says IBM may trade below estimates of intrinsic value based on discounted cash flow, earnings and cash-flow multiples. Its long-term return, sizable dividend and reported $1.69-per-share distribution strengthen the income and value case. IBM Stock Could Be Below Fair Value Despite Cautious Broader Checks Positive Sentiment: AI and strategic investments broaden IBM’s growth prospects. IBM remains a favored long-term AI stock among retail investors, while IBM Ventures’ investment in physics-acceleration company BQP provides additional exposure to advanced computing. IBM Ventures Backs Physics Acceleration Firm BQP Neutral Sentiment: IBM’s latest trading-session advance reflected broader market strength, but the company’s shares remain below both their 50-day and 200-day moving averages, indicating that technical momentum is still mixed. IBM Beats Stock Market Upswing Negative Sentiment: A law-firm investigation adds headline and litigation risk. Bleichmar Fonti & Auld announced an investigation into potential misrepresentations concerning IBM’s business deal pace. The inquiry does not establish wrongdoing, but it could pressure the stock if additional claims or weak bookings emerge. IBM Under Investigation for Securities Fraud (Free Report)

International Business Machines Corporation (IBM) is a global technology and consulting company headquartered in Armonk, New York. Founded in 1911 as the Computing-Tabulating-Recording Company (CTR) and renamed IBM in 1924, the company has evolved from early electromechanical machines to a diversified technology provider serving enterprises and governments worldwide. IBM is publicly traded on the New York Stock Exchange under the ticker symbol IBM.

IBM’s principal businesses encompass cloud computing and software, infrastructure and systems, consulting and technology services, and research and development.

Read More Five stocks we like better than International Business Machines The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for International Business Machines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Business Machines and related companies with MarketBeat.com's FREE daily email newsletter.

Flossbach Von Storch SE purchased a new stake in International Business Machines Corporation (NYSE:IBM – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 208,507 shares of the technology company’s stock, valued at approximately $58,634,000.

Several other institutional investors also recently modified their holdings of the company. Basepoint Wealth LLC acquired a new position in International Business Machines during the fourth quarter worth approximately $25,000. Cornerstone Financial Management LLC acquired a new position in shares of International Business Machines during the 4th quarter worth approximately $28,000. Harborfront Financial Group LLC bought a new stake in shares of International Business Machines in the second quarter valued at approximately $27,000. SWAN Capital LLC bought a new position in International Business Machines during the 3rd quarter worth $28,000. Finally, Bare Financial Services Inc raised its stake in International Business Machines by 114.6% in the second quarter. Bare Financial Services Inc now owns 103 shares of the technology company’s stock valued at $29,000 after purchasing an additional 55 shares in the last quarter. 58.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity In other news, SVP Robert Thomas sold 25,000 shares of the stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $230.32, for a total value of $5,758,000.00. Following the completion of the sale, the senior vice president owned 47,800 shares in the company, valued at $11,009,296. This represents a 34.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.27% of the stock is currently owned by insiders.

Analyst Ratings Changes A number of brokerages have weighed in on IBM. JPMorgan Chase & Co. reduced their target price on International Business Machines from $291.00 to $250.00 and set an “overweight” rating on the stock in a report on Friday, July 17th. Roth Capital reissued a “buy” rating on shares of International Business Machines in a report on Wednesday, June 3rd. Jefferies Financial Group decreased their price target on shares of International Business Machines from $320.00 to $260.00 and set a “buy” rating for the company in a research report on Tuesday, July 21st. Barclays dropped their price target on shares of International Business Machines from $288.00 to $262.00 and set an “overweight” rating for the company in a research note on Thursday, July 23rd. Finally, Needham & Company LLC assumed coverage on shares of International Business Machines in a research note on Wednesday, June 3rd. They issued a “buy” rating on the stock. Sixteen equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $265.90. Read Our Latest Analysis on IBM

Here are the key news stories impacting International Business Machines this week:

Positive Sentiment: Quantum-computing advances support IBM’s growth narrative. IBM reportedly achieved a 25-fold throughput improvement, reinforcing its position in quantum hardware and software and adding to investor enthusiasm around emerging technology opportunities. Quantum Computing News: IBM Hits 25x Throughput Gain, RGTI Shows Up to 100x Speedup Positive Sentiment: Valuation and shareholder returns are attracting buyers. One analysis says IBM may trade below estimates of intrinsic value based on discounted cash flow, earnings and cash-flow multiples. Its long-term return, sizable dividend and reported $1.69-per-share distribution strengthen the income and value case. IBM Stock Could Be Below Fair Value Despite Cautious Broader Checks Positive Sentiment: AI and strategic investments broaden IBM’s growth prospects. IBM remains a favored long-term AI stock among retail investors, while IBM Ventures’ investment in physics-acceleration company BQP provides additional exposure to advanced computing. IBM Ventures Backs Physics Acceleration Firm BQP Neutral Sentiment: IBM’s latest trading-session advance reflected broader market strength, but the company’s shares remain below both their 50-day and 200-day moving averages, indicating that technical momentum is still mixed. IBM Beats Stock Market Upswing Negative Sentiment: A law-firm investigation adds headline and litigation risk. Bleichmar Fonti & Auld announced an investigation into potential misrepresentations concerning IBM’s business deal pace. The inquiry does not establish wrongdoing, but it could pressure the stock if additional claims or weak bookings emerge. IBM Under Investigation for Securities Fraud International Business Machines Stock Performance Shares of IBM opened at $234.00 on Friday. International Business Machines Corporation has a one year low of $199.19 and a one year high of $332.46. The company has a market cap of $220.46 billion, a PE ratio of 20.76, a P/E/G ratio of 2.21 and a beta of 0.71. The stock has a 50-day moving average of $242.40 and a 200-day moving average of $247.21. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.79 and a quick ratio of 0.74.

International Business Machines (NYSE:IBM – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The technology company reported $2.93 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.93. International Business Machines had a return on equity of 35.65% and a net margin of 15.52%.The business had revenue of $17.16 billion for the quarter, compared to the consensus estimate of $17.46 billion. During the same period in the prior year, the business earned $2.80 EPS. The firm’s revenue for the quarter was up 1.1% on a year-over-year basis. On average, equities research analysts predict that International Business Machines Corporation will post 12.33 EPS for the current fiscal year.

International Business Machines Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Shareholders of record on Monday, August 10th will be paid a dividend of $1.69 per share. The ex-dividend date is Monday, August 10th. This represents a $6.76 dividend on an annualized basis and a yield of 2.9%. International Business Machines’s payout ratio is 59.98%.

About International Business Machines (Free Report)

International Business Machines Corporation (IBM) is a global technology and consulting company headquartered in Armonk, New York. Founded in 1911 as the Computing-Tabulating-Recording Company (CTR) and renamed IBM in 1924, the company has evolved from early electromechanical machines to a diversified technology provider serving enterprises and governments worldwide. IBM is publicly traded on the New York Stock Exchange under the ticker symbol IBM.

IBM’s principal businesses encompass cloud computing and software, infrastructure and systems, consulting and technology services, and research and development.

Featured Stories Five stocks we like better than International Business Machines The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for International Business Machines Corporation (NYSE:IBM – Free Report).

Receive News & Ratings for International Business Machines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Business Machines and related companies with MarketBeat.com's FREE daily email newsletter.

Jupiter Topco LLC bought a new position in The Gap, Inc. (NYSE:GAP – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 107,866 shares of the company’s stock, valued at approximately $2,017,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Cullen Frost Bankers Inc. bought a new position in shares of GAP in the 4th quarter worth approximately $26,000. Plato Investment Management Ltd bought a new stake in GAP during the fourth quarter valued at approximately $28,000. Global Retirement Partners LLC purchased a new stake in GAP during the second quarter valued at approximately $29,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in GAP during the second quarter valued at approximately $50,000. Finally, Quantbot Technologies LP bought a new position in GAP in the second quarter worth approximately $73,000. Hedge funds and other institutional investors own 58.81% of the company’s stock.

Analyst Upgrades and Downgrades GAP has been the topic of several analyst reports. The Goldman Sachs Group lifted their price target on shares of GAP from $25.00 to $27.00 and gave the stock a “buy” rating in a research note on Monday. Bank of America raised their target price on GAP from $26.00 to $27.00 and gave the stock a “neutral” rating in a report on Friday, August 28th. JPMorgan Chase & Co. restated a “neutral” rating and set a $27.00 target price (down from $35.00) on shares of GAP in a research note on Friday, May 29th. Morgan Stanley upped their target price on shares of GAP from $21.00 to $23.00 and gave the stock an “equal weight” rating in a report on Friday, August 28th. Finally, Jefferies Financial Group lowered GAP from a “buy” rating to a “hold” rating and cut their price target for the stock from $29.00 to $23.00 in a research note on Wednesday, August 12th. Two investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $27.36.

Get Our Latest Analysis on GAP GAP Stock Up 1.1% NYSE GAP opened at $22.31 on Friday. The Gap, Inc. has a 12 month low of $18.11 and a 12 month high of $29.36. The company has a current ratio of 1.82, a quick ratio of 1.11 and a debt-to-equity ratio of 0.38. The stock has a market cap of $7.84 billion, a PE ratio of 6.66, a P/E/G ratio of 0.94 and a beta of 2.08. The stock’s 50 day moving average is $20.19 and its 200 day moving average is $22.69.

GAP (NYSE:GAP – Get Free Report) last announced its quarterly earnings data on Thursday, August 27th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.04. The business had revenue of $3.65 billion during the quarter, compared to analyst estimates of $3.69 billion. GAP had a net margin of 8.14% and a return on equity of 19.72%. The company’s revenue was down 2.0% on a year-over-year basis. During the same period last year, the firm posted $0.57 EPS. GAP has set its FY 2026 guidance at 2.350-2.450 EPS. Research analysts predict that The Gap, Inc. will post 2.41 EPS for the current fiscal year.

GAP Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Wednesday, October 7th will be paid a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend is Wednesday, October 7th. GAP’s dividend payout ratio (DPR) is presently 20.90%.

Key Headlines Impacting GAP Here are the key news stories impacting GAP this week:

Positive Sentiment: New handbag strategy could expand growth opportunities: Gap is introducing “GapBag” for fall 2026, featuring handbags designed by Reed Krakoff. The move expands the brand into the lucrative accessories market and could increase average customer spending and diversify revenue beyond apparel. Gap introduces GapBag for fall 2026 with handbags by Reed Krakoff Positive Sentiment: Momentum factors remain favorable: Zacks highlighted GAP as a strong momentum stock, which may attract technical and quantitative investors after the shares moved above their 50-day average. Why Gap is a strong momentum stock Neutral Sentiment: Analyst sentiment is cautious: The Gap received an average “Hold” rating, suggesting Wall Street sees balanced upside and downside rather than a clear catalyst for re-rating. The Gap receives average Hold rating Neutral Sentiment: CEO Richard Dickson is scheduled to participate in the Goldman Sachs Global Consumer & Retail Conference on September 14. The event could provide updates on strategy, sales trends and the handbag rollout, but no new financial guidance was announced. Gap to participate in Goldman Sachs conference Neutral Sentiment: Gap also announced a New York City youth education partnership with FIT and BroSis. The initiative supports brand goodwill but is unlikely to materially affect near-term earnings. Gap, FIT and BroSis partnership GAP Company Profile (Free Report)

Gap Inc is a global specialty retailer renowned for its portfolio of apparel and accessories brands, including Gap, Banana Republic, Old Navy and Athleta. The company designs, sources and markets clothing across a broad price range and style spectrum, catering to men, women and children. Its offerings extend from everyday wardrobe essentials such as denim, tees and outerwear to performance and lifestyle pieces, reflecting each brand’s distinct identity and price point.

Founded in San Francisco in 1969 by Donald and Doris Fisher, Gap Inc has grown into one of the world’s largest apparel companies.

Further Reading Five stocks we like better than GAP The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding GAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Gap, Inc. (NYSE:GAP – Free Report).

Receive News & Ratings for GAP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GAP and related companies with MarketBeat.com's FREE daily email newsletter.

The first half of 2026 was a tough time for software stock investors. The sector experienced a massive sell-off, with top names, including Salesforce (CRM +2.92%), dropping sharply as fears of AI displacing enterprise software led many investors to reevaluate the segment's top stocks.

Salesforce CEO Marc Benioff told investors this isn't the first so-called "SaaSpocalypse" he's seen in his tenure as head of the leading enterprise software company. He called it "a great buying opportunity" during the company's fourth-quarter earnings call in February and thanked the board for authorizing a $50 billion share repurchase program, including a $25 billion accelerated repurchase. He executed within weeks, issuing debt and buying back the stock in a massive bet on the company.

And now it's paying off. Salesforce's share price is up 38% since the end of March, getting another leg up with the company's second-quarter earnings report in late August. Investors wondering if they missed the opportunity to buy the SaaS stock could be in luck. It still looks like an incredible opportunity, given several key announcements in the company's earnings report.

Image source: Getty Images.

Did Salesforce just put the AI fears to bed? Salesforce reported solid earnings for the second quarter, but investors will need to dig a little deeper to understand what drove the market to push the stock price up more than 20% after the news.

First, the company reported revenue at the top end of its guidance and saw remaining performance obligations grow at 11%. Current remaining performance obligations climbed 14%, giving credence to management's standing projection that it'll experience revenue acceleration in the back half of 2026. That's further supported by management's guidance, which included a raise in its full-year revenue outlook.

More encouraging is that the revenue growth is being driven by artificial intelligence (AI). "We're seeing incredible demand for our AI and data products, with [annual recurring revenue] about to cross $4 billion," Benioff said in the press release. That's a 210% increase in AI-related revenue year over year.

Premium Feature

Moneyball Superscore

83/100

Today's Change

(

2.92

%) $

7.50

Current Price

$

264.43

Building on that, it announced a partnership with Anthropic and introduced Claudeforce. The first set of products in Claudeforce will enable users to take actions right from a Claude chatbot window. It allows a Claude agent to access data within Salesforce and enables users to create apps and uncover answers buried in company data without any user interface constraints. It's also integrating Claude deeper into Agentforce and Slack.

The partnership reinforces Benioff's assertion that Salesforce's integration with businesses and its ability to collect and store enterprise data are essential, and the company's software will serve as an important layer that large language models can work on top of.

Salesforce is spending heavily on developing and marketing its AI efforts, though. That resulted in operating margin compression and a slight downward revision in full-year operating margin. Generally accepted accounting principles (GAAP) operating margin is now expected to come in at 20.1% for the full year, but non-GAAP operating margin remains unchanged at 34.3% for the year.

Despite the big jump in the stock price, Salesforce stock still looks cheap relative to its growth potential. Management may provide another update to its long-term growth targets later this month, but last year, it suggested it could grow revenue at a double-digit rate through the end of the decade while expanding the adjusted operating margin to about 40%.

The most recent earnings results should put some doubts about its potential growth to rest, but the market still fears that management is overly optimistic. That's why shares trade for just 16 times earnings expectations.

But even if management proves somewhat overly optimistic, the stock can still climb higher from here. As AI-related revenue becomes a bigger part of the business, it strikes more deals like Claudeforce, and revenue continues to compound at a double-digit rate, it should see some operating leverage as it scales its AI efforts. That should support strong organic earnings growth.

Meanwhile, the company is generating billions in free cash flow every year. That cash is used for additional acquisitions to bolster growth, with the rest going toward share repurchases. There's still about $23 billion of its $50 billion repurchase authorization remaining. That should push earnings-per-share growth even higher.

With a solid business that's proving to be a beneficiary of AI more than a victim of it, investors may still be undervaluing Salesforce right now.

Jupiter Topco LLC purchased a new stake in Kinross Gold Corporation (NYSE:KGC – Free Report) (TSE:K) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 76,332 shares of the mining company’s stock, valued at approximately $1,807,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. U S Global Investors Inc. lifted its position in Kinross Gold by 95.4% in the first quarter. U S Global Investors Inc. now owns 195,363 shares of the mining company’s stock valued at $5,962,000 after acquiring an additional 95,363 shares during the last quarter. SteelPeak Wealth LLC purchased a new position in shares of Kinross Gold during the first quarter worth about $2,263,000. TD Asset Management Inc grew its holdings in shares of Kinross Gold by 4.7% during the fourth quarter. TD Asset Management Inc now owns 5,879,190 shares of the mining company’s stock worth $165,814,000 after purchasing an additional 261,861 shares during the last quarter. Man Group plc lifted its holdings in shares of Kinross Gold by 7.6% in the 4th quarter. Man Group plc now owns 12,526,669 shares of the mining company’s stock valued at $352,751,000 after purchasing an additional 882,373 shares during the last quarter. Finally, Deutsche Bank AG purchased a new stake in shares of Kinross Gold in the 2nd quarter valued at about $217,800,000. Institutional investors and hedge funds own 63.69% of the company’s stock.

Analyst Ratings Changes A number of research firms recently issued reports on KGC. Scotiabank dropped their price target on Kinross Gold from $45.00 to $41.00 and set a “sector outperform” rating on the stock in a research note on Tuesday, July 14th. Zacks Research cut Kinross Gold from a “hold” rating to a “strong sell” rating in a research note on Monday, July 13th. Weiss Ratings cut Kinross Gold from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, July 28th. UBS Group decreased their price objective on Kinross Gold from $38.00 to $30.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Finally, Jefferies Financial Group lowered their target price on shares of Kinross Gold from $41.00 to $38.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $38.43.

Read Our Latest Stock Analysis on Kinross Gold Kinross Gold Stock Up 4.5% Kinross Gold stock opened at $31.63 on Friday. Kinross Gold Corporation has a twelve month low of $21.49 and a twelve month high of $39.11. The stock has a 50 day moving average of $26.25 and a two-hundred day moving average of $29.00. The company has a current ratio of 2.89, a quick ratio of 1.95 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $37.47 billion, a price-to-earnings ratio of 11.98, a PEG ratio of 0.82 and a beta of 0.84.

Kinross Gold (NYSE:KGC – Get Free Report) (TSE:K) last released its earnings results on Wednesday, July 29th. The mining company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.05. Kinross Gold had a return on equity of 34.00% and a net margin of 37.52%.The business had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.24 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 29.5% compared to the same quarter last year. As a group, research analysts expect that Kinross Gold Corporation will post 2.61 earnings per share for the current year.

Kinross Gold Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Thursday, August 20th. Kinross Gold’s dividend payout ratio (DPR) is 6.06%.

Kinross Gold Company Profile (Free Report)

Kinross Gold Corporation (NYSE: KGC) is a Toronto-based precious metals mining company primarily focused on the exploration, development and production of gold, with silver recovered as a by-product at some operations. The company’s activities span the full mining lifecycle, including discovery and resource delineation, mine construction and operation, ore processing, and eventual site reclamation and closure. Kinross sells refined gold produced at its processing facilities and manages associated logistics and processing arrangements to deliver metal to market.

Kinross operates a portfolio of producing mines and development projects across multiple regions, with a significant presence in the Americas and West Africa.

Featured Stories Five stocks we like better than Kinross Gold The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding KGC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kinross Gold Corporation (NYSE:KGC – Free Report) (TSE:K).

Receive News & Ratings for Kinross Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinross Gold and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Dow's shares have gained 29.9% year to date, outperforming the industry's 22% increase.Dow expects more than $1.3B in 2026 self-help benefits, including $700M from its new initiative. Specialty silicones expansion, alkoxylation investments and cost actions are supporting higher-value growth. Dow Inc.’s (DOW - Free Report) shares have gained 29.9% so far this year. The company has also outperformed the Zacks Chemicals Diversified industry’s 22% rise over the same time frame.

DOW has been gaining from its cost-reduction and productivity improvement efforts, strategic expansion in high-growth markets and feedstock advantages in the Americas, even as it navigates a challenging macroeconomic environment.

Image Source: Zacks Investment Research

Let’s take a look into the factors that are driving DOW stock.

DOW Gains on High-Return Projects & Self-Help ActionsDow benefits from its differentiated portfolio and advantaged feedstock positions in the Americas. It remains focused on investing in attractive areas. Its broad portfolio, significant low-cost feedstock positions, global footprint and market reach place it in an advantageous position against competitors. While Dow faces headwinds from heightened macroeconomic and geopolitical uncertainties, it remains focused on growth actions in attractive end markets and executing high-return incremental growth projects in cost-advantaged regions.

Recent alkoxylation investments are contributing to growth in the Industrial Solutions business. The company is also expanding specialty silicones capabilities for mobility, electronics and healthcare, while increasing its emphasis on higher-value downstream applications. Dow has completed the shutdown of its higher-cost Barry, U.K., upstream siloxanes unit, shifting its silicones mix by more than 25% toward more stable and higher-margin businesses while maintaining value-chain integration.

 The Barry action is expected to provide about $60 million of EBITDA uplift in the second half of 2026. Dow also restarted its lowest-cost and most flexible European cracker in Terneuzen and remains on track to shut the Bohlen cracker by year-end 2027, actions aimed at improving its cost-curve position and regional flexibility. The Alberta project continues to progress on its revised timeline, with roughly 60% of capital expenditures already spent, most critical labor contracts awarded and incentives intact.

Dow continues to emphasize cost and operational discipline through restructuring, productivity and process simplification. The company materially completed its $1 billion 2025 cost program and delivered more than $300 million of in-period self-help benefits in the second quarter of 2026. It now expects more than $1.3 billion of total self-help benefits in 2026. DOW has launched the “Transform to Outperform” initiative to improve productivity, reduce complexity, streamline its end-to-end processes and enable improved returns. The initiative is expected to contribute about $700 million in 2026.

DOW’s Zacks Rank & Key PicksDOW currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks in the Basic Materials space are Worthington Steel, Inc. (WS - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avient Corporation (AVNT - Free Report) . WS currently carries a Zacks Rank #1 (Strong Buy), while CRS and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for WS’s current-year earnings stands at $3.4 per share, implying a 52.5% year-over-year increase. The Zacks Consensus Estimate for WS’s current-year earnings has moved up 25.9% over the past 60 days.

The Zacks Consensus Estimate for CRS’s current fiscal-year earnings is pegged at $13.28 per share, implying a 23.4% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in all of the trailing four quarters, with the average surprise being 8.4%.

 The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in all of the trailing four quarters, with the average surprise being 3.4%.

ING’s Warren Patterson and Ewa Manthey highlight that central banks, led by China and Poland, continued net Gold purchases in July, supporting structural demand despite a slower pace than last year. They add that Gold prices rose over 2% after weaker US employment data and comments from Federal Reserve official Christopher Waller suggesting openness to holding rates steady if inflation behaves.

Official demand and Fed rhetoric support"Central banks continued to add to gold reserves in July, reporting net purchases of 23 tonnes, according to World Gold Council data. Emerging market central banks remained the main buyers, led by China and Poland. China's central bank extended its buying streak to 21 consecutive months, adding 20 tonnes."

"Although central bank buying has slowed compared to a year ago, official sector demand continues to provide support for the gold market. Ongoing reserve diversification efforts among emerging economies should help sustain structural demand, even if purchases moderate from recent highs."

"Gold prices rose more than 2% on Thursday following a weaker-than-expected ADP employment report on Wednesday. Comments from US Federal Reserve official Christopher Waller, suggesting he is open to keeping rates on hold at the next FOMC meeting (assuming no surprises on the inflation front), provided an additional boost."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)

Bank of Nova Scotia acquired a new position in Costco Wholesale Corporation (NASDAQ:COST – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 274,678 shares of the retailer’s stock, valued at approximately $256,954,000. Bank of Nova Scotia owned about 0.06% of Costco Wholesale at the end of the most recent quarter.

Several other large investors have also modified their holdings of COST. Kirtland Hills Capital Management LLC acquired a new position in Costco Wholesale in the 2nd quarter valued at $2,204,000. Compass Financial Management LLC acquired a new position in Costco Wholesale during the 2nd quarter worth $4,502,000. Elevation Point Wealth Partners LLC bought a new stake in Costco Wholesale during the second quarter valued at about $16,837,000. Alta Advisers Ltd bought a new stake in Costco Wholesale during the second quarter valued at about $1,558,000. Finally, Daiichi Life Insurance Co. Ltd. acquired a new stake in shares of Costco Wholesale in the second quarter valued at about $24,459,000. 68.48% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth A number of equities analysts have recently commented on COST shares. Mizuho set a $1,100.00 price objective on Costco Wholesale in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $1,120.00 target price on shares of Costco Wholesale in a report on Thursday, August 6th. HC Wainwright reaffirmed a “buy” rating on shares of Costco Wholesale in a research report on Monday, June 1st. BTIG Research reiterated a “buy” rating and set a $1,125.00 price target on shares of Costco Wholesale in a report on Thursday. Finally, Bank of America increased their price objective on Costco Wholesale from $1,185.00 to $1,200.00 and gave the company a “buy” rating in a research report on Friday, May 29th. Twenty-one analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Costco Wholesale currently has an average rating of “Moderate Buy” and an average target price of $1,059.53.

View Our Latest Stock Report on Costco Wholesale Costco Wholesale Stock Down 0.3% COST stock opened at $925.41 on Friday. Costco Wholesale Corporation has a twelve month low of $844.06 and a twelve month high of $1,096.50. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.17. The company has a market cap of $410.40 billion, a PE ratio of 46.55, a price-to-earnings-growth ratio of 3.85 and a beta of 0.86. The business’s 50-day simple moving average is $944.31 and its 200 day simple moving average is $978.18.

Costco Wholesale Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, August 7th. Stockholders of record on Friday, July 24th were issued a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, July 24th. Costco Wholesale’s dividend payout ratio (DPR) is presently 29.58%.

Costco Wholesale News Roundup Here are the key news stories impacting Costco Wholesale this week:

Positive Sentiment: Strong August and fiscal-year sales: Costco reported August net sales of $23.70 billion, up 9.9% year over year. Fourth-quarter sales rose 11.3% to $93.9 billion, while fiscal-year sales increased 10.2% to $297.3 billion. Total comparable sales grew 8.4% for August and the fiscal year, and digitally enabled sales rose 17.9% for the month and 20.9% for the year. Costco August Sales Results Positive Sentiment: Analysts remain constructive: BTIG reaffirmed its Buy rating with a $1,125 price target, while Bank of America maintained a Buy rating and a $1,200 target. These targets imply substantial upside and suggest analysts believe Costco’s membership model and sales momentum support its premium valuation. BTIG Costco Rating Neutral Sentiment: Mixed analyst signal: DA Davidson reaffirmed a Neutral rating but lifted its price target to $1,000, indicating limited conviction even while acknowledging potential appreciation. Neutral Sentiment: Long-term optimism: Commentary argues Costco could eventually surpass Home Depot and Lowe’s in market value if it sustains membership growth, warehouse expansion and consistent execution. This is a long-range thesis rather than a near-term catalyst. Costco Long-Term Valuation Forecast Negative Sentiment: DOJ beef-pricing investigation: The Justice Department is requesting records from Costco and other major retailers regarding beef prices, costs, margins and purchasing strategies. The inquiry creates potential legal, regulatory and operational risks, although no wrongdoing has been established. DOJ Beef Price Inquiry Negative Sentiment: Costco Next shutdown: The abrupt ending of the online Costco Next marketplace disappointed some members and raises questions about the company’s digital strategy, though the direct financial effect appears limited. Costco Next Shutdown Insider Buying and Selling at Costco Wholesale In other news, Director Kenneth Denman sold 885 shares of the business’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $957.45, for a total transaction of $847,343.25. Following the sale, the director directly owned 4,779 shares in the company, valued at approximately $4,575,653.55. The trade was a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.10% of the company’s stock.

(Free Report)

Costco Wholesale Corporation operates a global chain of membership-only warehouse clubs that sell a wide array of merchandise in bulk at discounted prices. The company’s product mix includes groceries, fresh and frozen food, household goods, electronics, apparel, and seasonal items, augmented by its prominent private-label brand, Kirkland Signature. Costco’s business model centers on annual membership fees and high-volume, low-margin sales, designed to drive repeat purchasing and strong customer loyalty among both consumers and small-business buyers.

Beyond merchandise, Costco provides a range of ancillary services that complement its warehouses, including gasoline stations, pharmacy and optical services, hearing aid centers, photo services, and travel and insurance products.

Read More Five stocks we like better than Costco Wholesale The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Costco Wholesale Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Costco Wholesale and related companies with MarketBeat.com's FREE daily email newsletter.

Aberdeen Wealth Management LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 9,276 shares of the company’s stock, valued at approximately $2,334,000. AbbVie makes up approximately 1.1% of Aberdeen Wealth Management LLC’s investment portfolio, making the stock its 14th biggest position.

A number of other institutional investors have also modified their holdings of the company. Visionary Wealth Advisors purchased a new stake in shares of AbbVie during the second quarter worth about $14,980,000. Cullen Capital Management LLC purchased a new position in shares of AbbVie in the second quarter worth $1,800,000. Whalen Wealth Management Inc. purchased a new position in shares of AbbVie in the second quarter worth $931,000. Dearborn Partners LLC acquired a new stake in shares of AbbVie during the second quarter worth $27,926,000. Finally, Trail Ridge Investment Advisors LLC acquired a new stake in shares of AbbVie during the second quarter worth $525,000. 70.23% of the stock is currently owned by institutional investors.

AbbVie Price Performance NYSE ABBV opened at $260.69 on Friday. AbbVie Inc. has a 1 year low of $190.75 and a 1 year high of $267.47. The company has a market capitalization of $460.58 billion, a PE ratio of 73.64, a P/E/G ratio of 1.18 and a beta of 0.29. The company has a fifty day moving average of $254.57 and a 200 day moving average of $229.87.

AbbVie (NYSE:ABBV – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $3.65 earnings per share for the quarter, topping the consensus estimate of $3.61 by $0.04. The company had revenue of $16.99 billion for the quarter, compared to the consensus estimate of $16.80 billion. AbbVie had a negative return on equity of 422.07% and a net margin of 9.80%.The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period last year, the firm earned $2.97 EPS. AbbVie has set its Q3 2026 guidance at 3.840-3.880 EPS. Research analysts expect that AbbVie Inc. will post 14.05 earnings per share for the current year. AbbVie Announces Dividend The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Wednesday, July 15th were issued a dividend of $1.73 per share. This represents a $6.92 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Wednesday, July 15th. AbbVie’s dividend payout ratio (DPR) is 195.48%.

Analyst Ratings Changes Several research firms recently issued reports on ABBV. Piper Sandler upped their target price on AbbVie from $298.00 to $303.00 and gave the company an “overweight” rating in a research report on Thursday, August 20th. Guggenheim lifted their price target on AbbVie from $261.00 to $288.00 and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Citigroup boosted their price target on AbbVie from $230.00 to $260.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. JPMorgan Chase & Co. increased their price objective on AbbVie from $260.00 to $280.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Finally, Royal Bank Of Canada raised their price objective on AbbVie from $260.00 to $280.00 and gave the stock an “outperform” rating in a research note on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $275.95.

Get Our Latest Report on AbbVie

Key Headlines Impacting AbbVie Here are the key news stories impacting AbbVie this week:

Positive Sentiment: Etentamig delivers positive Phase 3 results. AbbVie said its CERVINO trial met both primary endpoints in relapsed/refractory multiple myeloma. The treatment produced a 74% objective response rate and reduced the risk of disease progression or death by 60% versus standard therapies. The results support a potential new oncology growth driver and may allow AbbVie to compete for share in the increasingly competitive multiple myeloma market. AbbVie CERVINO Phase 3 results Positive Sentiment: Apogee expands AbbVie’s immunology pipeline. AbbVie completed its approximately $10.9 billion acquisition of Apogee Therapeutics, adding late-stage zumilokibart for atopic dermatitis and additional programs targeting asthma and other inflammatory diseases. The deal strengthens AbbVie’s post-Humira growth prospects and diversifies its pipeline. AbbVie completes Apogee acquisition Neutral Sentiment: Full-year earnings guidance was reaffirmed. AbbVie maintained adjusted 2026 EPS guidance of $13.87 to $14.07 and third-quarter guidance of $3.84 to $3.88. The range is broadly consistent with expectations, but its midpoint is slightly below the current consensus estimate of $14.02, limiting the immediate upside reaction. Negative Sentiment: Acquisition costs create near-term pressure. The Apogee transaction is expected to dilute earnings initially and become accretive only later, reportedly around 2032. Investors may therefore focus on the substantial cash commitment and the long wait before financial benefits fully materialize. AbbVie Apogee acquisition analysis Insiders Place Their Bets In related news, EVP Nicholas Donoghoe sold 32,710 shares of AbbVie stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $250.00, for a total transaction of $8,177,500.00. Following the completion of the transaction, the executive vice president directly owned 74,430 shares in the company, valued at approximately $18,607,500. This trade represents a 30.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.06% of the company’s stock.

AbbVie Company Profile (Free Report)

AbbVie is a global, research-driven biopharmaceutical company that was created as a spin-off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois. The company focuses on discovering, developing and commercializing therapies for complex and often chronic medical conditions. Its operations span research and development, manufacturing, regulatory affairs and commercialization, with an emphasis on bringing specialty medicines to market across multiple therapeutic areas.

AbbVie’s product portfolio and pipeline cover several major therapeutic categories, including immunology, oncology, neuroscience, virology and women’s health.

Recommended Stories Five stocks we like better than AbbVie The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for AbbVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie and related companies with MarketBeat.com's FREE daily email newsletter.

Aberdeen Wealth Management LLC purchased a new position in shares of Micron Technology, Inc. (NASDAQ:MU – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,192 shares of the semiconductor manufacturer’s stock, valued at approximately $1,376,000. Micron Technology accounts for approximately 0.7% of Aberdeen Wealth Management LLC’s investment portfolio, making the stock its 26th biggest position.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Heritage Trust Co grew its holdings in shares of Micron Technology by 9.7% in the 4th quarter. Heritage Trust Co now owns 15,026 shares of the semiconductor manufacturer’s stock worth $4,289,000 after acquiring an additional 1,323 shares during the period. Castleark Management LLC acquired a new position in Micron Technology during the first quarter worth $3,709,000. Oppenheimer & Co. Inc. boosted its position in Micron Technology by 16.0% during the second quarter. Oppenheimer & Co. Inc. now owns 48,520 shares of the semiconductor manufacturer’s stock worth $56,006,000 after purchasing an additional 6,702 shares in the last quarter. Legacy Wealth Management LLC MS boosted its position in Micron Technology by 73.3% during the second quarter. Legacy Wealth Management LLC MS now owns 3,544 shares of the semiconductor manufacturer’s stock worth $4,091,000 after purchasing an additional 1,499 shares in the last quarter. Finally, Financial Synergies Wealth Advisors Inc. acquired a new stake in Micron Technology in the fourth quarter valued at $1,316,000. 80.84% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Micron Technology In other news, CEO Sanjay Mehrotra sold 40,000 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $968.90, for a total transaction of $38,756,000.00. Following the sale, the chief executive officer owned 264,503 shares in the company, valued at $256,276,956.70. This trade represents a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP April Arnzen sold 40,000 shares of Micron Technology stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $1,083.94, for a total value of $43,357,600.00. Following the completion of the sale, the executive vice president directly owned 85,737 shares of the company’s stock, valued at approximately $92,933,763.78. This represents a 31.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 177,204 shares of company stock valued at $182,156,264. 0.24% of the stock is currently owned by insiders.

Micron Technology Stock Performance Shares of NASDAQ MU opened at $958.16 on Friday. The company has a 50-day simple moving average of $937.47 and a 200-day simple moving average of $732.52. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.42 and a quick ratio of 2.98. The company has a market cap of $1.08 trillion, a PE ratio of 21.69, a price-to-earnings-growth ratio of 0.61 and a beta of 2.22. Micron Technology, Inc. has a 12 month low of $118.52 and a 12 month high of $1,255.00. Micron Technology (NASDAQ:MU – Get Free Report) last announced its quarterly earnings data on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $21.39 by $3.72. Micron Technology had a net margin of 55.91% and a return on equity of 71.13%. The business had revenue of $41.46 billion for the quarter, compared to the consensus estimate of $35.91 billion. During the same quarter in the prior year, the firm posted $1.91 earnings per share. The company’s quarterly revenue was up 345.8% compared to the same quarter last year. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. On average, equities analysts anticipate that Micron Technology, Inc. will post 72.93 earnings per share for the current year.

Micron Technology Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 21st. Shareholders of record on Monday, July 6th were paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, July 6th. Micron Technology’s dividend payout ratio is currently 1.36%.

Trending Headlines about Micron Technology Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Record results and upbeat outlook support the bull case. Micron’s fiscal third-quarter revenue reached $41.46 billion, while non-GAAP EPS was $25.11, both well above expectations. Management’s fiscal fourth-quarter outlook—approximately $50 billion in revenue, $31 in non-GAAP EPS and an estimated 86% gross margin—has reinforced expectations for another record quarter. Micron’s Q4 2026 Period Will Be Another Record Quarter Positive Sentiment: AI demand is extending beyond high-bandwidth memory (HBM). Hyperscaler spending is tightening supplies of HBM, DRAM and NAND, driving contract-price increases and diverting production away from consumer electronics. Micron also has 16 strategic customer agreements, including multiyear commitments and pricing protections, improving revenue visibility and reducing—though not eliminating—the impact of traditional memory cycles. Micron: The AI Memory Shortage Has Spread Beyond HBM Positive Sentiment: Analysts and institutional investors remain broadly constructive. Several reports argue that sold-out HBM capacity, strong pricing and a valuation below some semiconductor peers leave room for further gains. Soros Fund Management increased its reported Micron position nearly eightfold in the second quarter, although other investors, including David Tepper, reduced their exposure. Soros Fund Management Increased Micron Nearly Eightfold Neutral Sentiment: Micron also received a legal tailwind. A U.S. appeals court upheld Patent Office rulings invalidating five Netlist memory patents, removing a potential source of litigation pressure. Netlist Loses Patent Infringement Appeal Against Micron Negative Sentiment: China’s CXMT is gaining DRAM share, increasing long-term competition. Reports place CXMT near 10% of the DRAM market, raising concerns that Chinese capacity could eventually pressure pricing and market share, despite Micron’s near-term production being largely committed under contracts. Chinese Chipmaker CXMT Surges to 10% DRAM Share Negative Sentiment: High expectations and external risks are limiting enthusiasm. Critics argue that the upcoming quarterly report must deliver near-perfect execution after MU’s major rally. A potentially restrictive Federal Reserve decision could pressure richly valued growth stocks, while labor tensions in Taiwan—including demands for unusually large bonuses and a possible strike vote—create supply-continuity and margin risks. The Fed’s September Decision Could Hit Micron Harder Than Its Own Earnings Wall Street Analyst Weigh In A number of brokerages have recently weighed in on MU. Wells Fargo & Company raised their price target on Micron Technology from $1,220.00 to $1,525.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th. KeyCorp reissued an “overweight” rating on shares of Micron Technology in a research note on Monday, July 20th. BMO Capital Markets assumed coverage on shares of Micron Technology in a report on Friday, August 21st. They set an “outperform” rating and a $1,300.00 target price for the company. Wolfe Research set a $1,500.00 target price on shares of Micron Technology in a report on Thursday, June 25th. Finally, DA Davidson upped their price target on shares of Micron Technology from $1,500.00 to $2,000.00 and gave the company a “buy” rating in a report on Thursday, June 25th. Four investment analysts have rated the stock with a Strong Buy rating, thirty-one have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Micron Technology has an average rating of “Buy” and a consensus price target of $1,295.63.

View Our Latest Research Report on MU

Micron Technology Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Featured Stories Five stocks we like better than Micron Technology The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Brandywine Managers LLC purchased a new position in Micron Technology, Inc. (NASDAQ:MU – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,416 shares of the semiconductor manufacturer’s stock, valued at approximately $1,634,000. Micron Technology makes up 0.8% of Brandywine Managers LLC’s investment portfolio, making the stock its 13th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. M.E. Allison & CO. Inc. boosted its holdings in shares of Micron Technology by 0.8% in the second quarter. M.E. Allison & CO. Inc. now owns 1,324 shares of the semiconductor manufacturer’s stock worth $1,528,000 after buying an additional 11 shares during the period. Cherrydale Wealth Management LLC raised its holdings in shares of Micron Technology by 1.4% during the second quarter. Cherrydale Wealth Management LLC now owns 972 shares of the semiconductor manufacturer’s stock valued at $1,122,000 after acquiring an additional 13 shares during the period. Bellevue Asset Management LLC raised its holdings in shares of Micron Technology by 25.5% during the second quarter. Bellevue Asset Management LLC now owns 64 shares of the semiconductor manufacturer’s stock valued at $74,000 after acquiring an additional 13 shares during the period. Mowery & Schoenfeld Wealth Management LLC lifted its position in shares of Micron Technology by 8.8% in the 2nd quarter. Mowery & Schoenfeld Wealth Management LLC now owns 161 shares of the semiconductor manufacturer’s stock valued at $186,000 after acquiring an additional 13 shares in the last quarter. Finally, Red Door Wealth Management LLC lifted its position in shares of Micron Technology by 0.7% in the 2nd quarter. Red Door Wealth Management LLC now owns 1,914 shares of the semiconductor manufacturer’s stock valued at $2,209,000 after acquiring an additional 14 shares in the last quarter. Institutional investors and hedge funds own 80.84% of the company’s stock.

Micron Technology Stock Performance Shares of MU stock opened at $958.16 on Friday. Micron Technology, Inc. has a fifty-two week low of $118.52 and a fifty-two week high of $1,255.00. The stock’s 50-day moving average is $937.47 and its two-hundred day moving average is $732.52. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.42 and a quick ratio of 2.98. The firm has a market cap of $1.08 trillion, a P/E ratio of 21.69, a PEG ratio of 0.61 and a beta of 2.22.

Micron Technology (NASDAQ:MU – Get Free Report) last announced its quarterly earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $21.39 by $3.72. The business had revenue of $41.46 billion during the quarter, compared to analyst estimates of $35.91 billion. Micron Technology had a return on equity of 71.13% and a net margin of 55.91%.The firm’s revenue was up 345.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.91 EPS. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. Analysts predict that Micron Technology, Inc. will post 72.93 earnings per share for the current fiscal year. Micron Technology Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 21st. Shareholders of record on Monday, July 6th were paid a $0.15 dividend. The ex-dividend date was Monday, July 6th. This represents a $0.60 dividend on an annualized basis and a yield of 0.1%. Micron Technology’s payout ratio is 1.36%.

Analysts Set New Price Targets Several research firms have weighed in on MU. Wells Fargo & Company lifted their price objective on shares of Micron Technology from $1,220.00 to $1,525.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. KeyCorp reaffirmed an “overweight” rating on shares of Micron Technology in a research report on Monday, July 20th. Bank of America lifted their price target on Micron Technology from $950.00 to $1,500.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. Rosenblatt Securities upped their price target on Micron Technology from $1,200.00 to $1,500.00 and gave the company a “buy” rating in a research report on Thursday, June 25th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $1,500.00 price objective on shares of Micron Technology in a research note on Thursday, June 25th. Four research analysts have rated the stock with a Strong Buy rating, thirty-one have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Micron Technology presently has a consensus rating of “Buy” and a consensus price target of $1,295.63.

Get Our Latest Stock Analysis on Micron Technology

Key Stories Impacting Micron Technology Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Record results and upbeat outlook support the bull case. Micron’s fiscal third-quarter revenue reached $41.46 billion, while non-GAAP EPS was $25.11, both well above expectations. Management’s fiscal fourth-quarter outlook—approximately $50 billion in revenue, $31 in non-GAAP EPS and an estimated 86% gross margin—has reinforced expectations for another record quarter. Micron’s Q4 2026 Period Will Be Another Record Quarter Positive Sentiment: AI demand is extending beyond high-bandwidth memory (HBM). Hyperscaler spending is tightening supplies of HBM, DRAM and NAND, driving contract-price increases and diverting production away from consumer electronics. Micron also has 16 strategic customer agreements, including multiyear commitments and pricing protections, improving revenue visibility and reducing—though not eliminating—the impact of traditional memory cycles. Micron: The AI Memory Shortage Has Spread Beyond HBM Positive Sentiment: Analysts and institutional investors remain broadly constructive. Several reports argue that sold-out HBM capacity, strong pricing and a valuation below some semiconductor peers leave room for further gains. Soros Fund Management increased its reported Micron position nearly eightfold in the second quarter, although other investors, including David Tepper, reduced their exposure. Soros Fund Management Increased Micron Nearly Eightfold Neutral Sentiment: Micron also received a legal tailwind. A U.S. appeals court upheld Patent Office rulings invalidating five Netlist memory patents, removing a potential source of litigation pressure. Netlist Loses Patent Infringement Appeal Against Micron Negative Sentiment: China’s CXMT is gaining DRAM share, increasing long-term competition. Reports place CXMT near 10% of the DRAM market, raising concerns that Chinese capacity could eventually pressure pricing and market share, despite Micron’s near-term production being largely committed under contracts. Chinese Chipmaker CXMT Surges to 10% DRAM Share Negative Sentiment: High expectations and external risks are limiting enthusiasm. Critics argue that the upcoming quarterly report must deliver near-perfect execution after MU’s major rally. A potentially restrictive Federal Reserve decision could pressure richly valued growth stocks, while labor tensions in Taiwan—including demands for unusually large bonuses and a possible strike vote—create supply-continuity and margin risks. The Fed’s September Decision Could Hit Micron Harder Than Its Own Earnings Insider Buying and Selling In other news, CEO Sanjay Mehrotra sold 40,000 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $968.90, for a total transaction of $38,756,000.00. Following the transaction, the chief executive officer owned 264,503 shares in the company, valued at approximately $256,276,956.70. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Sumit Sadana sold 15,000 shares of Micron Technology stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $934.29, for a total transaction of $14,014,350.00. Following the completion of the sale, the executive vice president directly owned 191,021 shares of the company’s stock, valued at approximately $178,469,010.09. The trade was a 7.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 177,204 shares of company stock valued at $182,156,264. 0.24% of the stock is owned by company insiders.

Micron Technology Company Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

See Also Five stocks we like better than Micron Technology The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Cibc World Market Inc. bought a new position in Micron Technology, Inc. (NASDAQ:MU – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 224,592 shares of the semiconductor manufacturer’s stock, valued at approximately $259,244,000.

Several other hedge funds and other institutional investors have also modified their holdings of MU. Castlefield Investment Partners LLP acquired a new position in Micron Technology in the 2nd quarter valued at approximately $6,189,000. Osbon Capital Management LLC acquired a new stake in Micron Technology in the 2nd quarter valued at approximately $182,000. OMERS ADMINISTRATION Corp acquired a new position in Micron Technology during the 2nd quarter valued at $396,868,000. Tribune Investment Group LP bought a new stake in Micron Technology in the 2nd quarter valued at $3,890,000. Finally, Osmosis Investment Management UK Ltd bought a new stake in shares of Micron Technology during the second quarter valued at approximately $34,840,000. Institutional investors and hedge funds own 80.84% of the company’s stock.

Key Stories Impacting Micron Technology Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Record results and upbeat outlook support the bull case. Micron’s fiscal third-quarter revenue reached $41.46 billion, while non-GAAP EPS was $25.11, both well above expectations. Management’s fiscal fourth-quarter outlook—approximately $50 billion in revenue, $31 in non-GAAP EPS and an estimated 86% gross margin—has reinforced expectations for another record quarter. Micron’s Q4 2026 Period Will Be Another Record Quarter Positive Sentiment: AI demand is extending beyond high-bandwidth memory (HBM). Hyperscaler spending is tightening supplies of HBM, DRAM and NAND, driving contract-price increases and diverting production away from consumer electronics. Micron also has 16 strategic customer agreements, including multiyear commitments and pricing protections, improving revenue visibility and reducing—though not eliminating—the impact of traditional memory cycles. Micron: The AI Memory Shortage Has Spread Beyond HBM Positive Sentiment: Analysts and institutional investors remain broadly constructive. Several reports argue that sold-out HBM capacity, strong pricing and a valuation below some semiconductor peers leave room for further gains. Soros Fund Management increased its reported Micron position nearly eightfold in the second quarter, although other investors, including David Tepper, reduced their exposure. Soros Fund Management Increased Micron Nearly Eightfold Neutral Sentiment: Micron also received a legal tailwind. A U.S. appeals court upheld Patent Office rulings invalidating five Netlist memory patents, removing a potential source of litigation pressure. Netlist Loses Patent Infringement Appeal Against Micron Negative Sentiment: China’s CXMT is gaining DRAM share, increasing long-term competition. Reports place CXMT near 10% of the DRAM market, raising concerns that Chinese capacity could eventually pressure pricing and market share, despite Micron’s near-term production being largely committed under contracts. Chinese Chipmaker CXMT Surges to 10% DRAM Share Negative Sentiment: High expectations and external risks are limiting enthusiasm. Critics argue that the upcoming quarterly report must deliver near-perfect execution after MU’s major rally. A potentially restrictive Federal Reserve decision could pressure richly valued growth stocks, while labor tensions in Taiwan—including demands for unusually large bonuses and a possible strike vote—create supply-continuity and margin risks. The Fed’s September Decision Could Hit Micron Harder Than Its Own Earnings Insider Activity In other Micron Technology news, Director Lynn A. Dugle sold 1,300 shares of Micron Technology stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $1,150.43, for a total transaction of $1,495,559.00. Following the transaction, the director directly owned 17,728 shares of the company’s stock, valued at approximately $20,394,823.04. The trade was a 6.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP April S. Arnzen sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $1,083.94, for a total transaction of $43,357,600.00. Following the completion of the transaction, the executive vice president owned 85,737 shares in the company, valued at $92,933,763.78. This trade represents a 31.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 177,204 shares of company stock valued at $182,156,264. 0.24% of the stock is currently owned by company insiders. Micron Technology Stock Up 0.2% NASDAQ MU opened at $958.16 on Friday. The company has a market cap of $1.08 trillion, a price-to-earnings ratio of 21.69, a PEG ratio of 0.61 and a beta of 2.22. The company has a current ratio of 3.42, a quick ratio of 2.98 and a debt-to-equity ratio of 0.05. Micron Technology, Inc. has a 1-year low of $118.52 and a 1-year high of $1,255.00. The company has a 50 day moving average of $937.47 and a 200-day moving average of $732.52.

Micron Technology (NASDAQ:MU – Get Free Report) last issued its earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 EPS for the quarter, beating the consensus estimate of $21.39 by $3.72. Micron Technology had a net margin of 55.91% and a return on equity of 71.13%. The company had revenue of $41.46 billion during the quarter, compared to analysts’ expectations of $35.91 billion. During the same period in the previous year, the company earned $1.91 EPS. The business’s revenue for the quarter was up 345.8% compared to the same quarter last year. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. On average, equities research analysts expect that Micron Technology, Inc. will post 72.93 earnings per share for the current fiscal year.

Micron Technology Announces Dividend The business also recently declared a quarterly dividend, which was paid on Tuesday, July 21st. Stockholders of record on Monday, July 6th were issued a dividend of $0.15 per share. The ex-dividend date was Monday, July 6th. This represents a $0.60 annualized dividend and a dividend yield of 0.1%. Micron Technology’s dividend payout ratio is 1.36%.

Wall Street Analysts Forecast Growth A number of research analysts have commented on MU shares. Zacks Research cut shares of Micron Technology from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 19th. BMO Capital Markets began coverage on Micron Technology in a research note on Friday, August 21st. They issued an “outperform” rating and a $1,300.00 target price on the stock. Stifel Nicolaus boosted their target price on Micron Technology from $550.00 to $1,500.00 and gave the company a “buy” rating in a research note on Thursday, June 18th. Raymond James Financial raised their price objective on shares of Micron Technology from $1,100.00 to $1,500.00 and gave the stock an “outperform” rating in a report on Thursday, June 25th. Finally, Morgan Stanley boosted their price objective on shares of Micron Technology from $1,050.00 to $1,200.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. Four research analysts have rated the stock with a Strong Buy rating, thirty-one have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Micron Technology presently has a consensus rating of “Buy” and an average target price of $1,295.63.

View Our Latest Research Report on MU

Micron Technology Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Recommended Stories Five stocks we like better than Micron Technology The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Blue Whale Capital LLP acquired a new position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 530,478 shares of the semiconductor manufacturer’s stock, valued at approximately $200,388,000. Broadcom comprises about 6.4% of Blue Whale Capital LLP’s portfolio, making the stock its 5th biggest holding.

Several other institutional investors have also recently made changes to their positions in the company. ROSS JOHNSON & Associates LLC boosted its holdings in Broadcom by 1,320.0% during the fourth quarter. ROSS JOHNSON & Associates LLC now owns 71 shares of the semiconductor manufacturer’s stock worth $25,000 after purchasing an additional 66 shares during the last quarter. Networth Advisors LLC grew its position in Broadcom by 546.2% in the 1st quarter. Networth Advisors LLC now owns 84 shares of the semiconductor manufacturer’s stock worth $26,000 after purchasing an additional 71 shares in the last quarter. SWAN Capital LLC increased its stake in Broadcom by 261.9% in the 4th quarter. SWAN Capital LLC now owns 76 shares of the semiconductor manufacturer’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Harborfront Financial Group LLC bought a new position in shares of Broadcom during the 2nd quarter worth approximately $38,000. Finally, Cherry Tree Wealth Management LLC lifted its position in shares of Broadcom by 44.9% during the 4th quarter. Cherry Tree Wealth Management LLC now owns 129 shares of the semiconductor manufacturer’s stock worth $45,000 after buying an additional 40 shares in the last quarter. Institutional investors own 76.43% of the company’s stock.

Analysts Set New Price Targets A number of equities analysts have recently weighed in on AVGO shares. Susquehanna restated a “positive” rating and issued a $490.00 target price (up from $450.00) on shares of Broadcom in a research note on Thursday, May 28th. Fox Advisors upgraded Broadcom to an “outperform” rating in a report on Thursday. UBS Group cut Broadcom from a “buy” rating to a “hold” rating in a research report on Thursday. KeyCorp restated an “overweight” rating and issued a $575.00 price objective on shares of Broadcom in a research note on Thursday. Finally, Evercore set a $578.00 target price on Broadcom in a research report on Thursday. Thirty-one research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Broadcom presently has a consensus rating of “Moderate Buy” and a consensus target price of $501.77.

View Our Latest Analysis on AVGO Broadcom Trading Down 2.7% Shares of AVGO stock opened at $357.16 on Friday. The company has a quick ratio of 2.01, a current ratio of 2.24 and a debt-to-equity ratio of 0.71. The firm has a market cap of $1.70 trillion, a P/E ratio of 45.61, a PEG ratio of 0.70 and a beta of 1.44. The company has a 50 day moving average of $383.71 and a 200-day moving average of $377.36. Broadcom Inc. has a 12-month low of $289.96 and a 12-month high of $495.00.

Broadcom (NASDAQ:AVGO – Get Free Report) last posted its quarterly earnings data on Wednesday, September 2nd. The semiconductor manufacturer reported $3.32 EPS for the quarter, beating the consensus estimate of $3.22 by $0.10. Broadcom had a return on equity of 50.76% and a net margin of 42.94%.The business had revenue of $29.59 billion for the quarter, compared to the consensus estimate of $29.24 billion. During the same quarter in the prior year, the business earned $1.69 earnings per share. Broadcom’s revenue for the quarter was up 85.5% on a year-over-year basis. Sell-side analysts anticipate that Broadcom Inc. will post 10.24 earnings per share for the current year.

Broadcom Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Monday, September 21st will be given a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, September 21st. Broadcom’s dividend payout ratio is currently 43.33%.

Key Broadcom News Here are the key news stories impacting Broadcom this week:

Positive Sentiment: Broadcom reported fiscal third-quarter revenue of $29.6 billion, up 86% year over year, and non-GAAP EPS of $3.32, exceeding estimates of $29.43 billion and $3.22. AI semiconductor revenue surged 221% to $16.7 billion, while free cash flow reached $13.7 billion. Broadcom fiscal third-quarter results Positive Sentiment: Management raised its fiscal 2027 AI revenue outlook to $115 billion and projected $230 billion in fiscal 2028, alongside confidence in fiscal 2027 EPS of at least $30. Analysts including Macquarie, Cantor Fitzgerald, BMO and Rosenblatt responded with upgrades or higher price targets, supporting the long-term AI investment case. Broadcom AI growth outlook Neutral Sentiment: Broadcom declared a quarterly dividend of $0.65 per share, payable September 30 to shareholders of record September 21. The dividend provides modest income but is unlikely to drive the stock’s near-term performance. Broadcom dividend announcement Negative Sentiment: Fiscal fourth-quarter revenue guidance of approximately $34.8 billion was below Wall Street’s roughly $35.0 billion expectation. Investors viewed the outlook as insufficient given AVGO’s premium valuation and elevated AI expectations, overshadowing the earnings beat. Broadcom forecasts quarterly revenue below estimates Negative Sentiment: Investors are also weighing supply constraints involving power, land, chips and substrates, along with customer concentration among major hyperscalers such as Alphabet, Anthropic and OpenAI. Competition from custom-chip rivals, including Marvell, adds uncertainty to the ambitious long-term forecast. Broadcom AI supply constraints Negative Sentiment: Recent disclosures that Third Point exited its Broadcom position and that company insiders have overwhelmingly sold shares may reinforce profit-taking concerns, although these transactions are not necessarily indicative of deteriorating fundamentals. Dan Loeb exits Broadcom position Insider Transactions at Broadcom In other news, Director Gayla Delly sold 1,890 shares of the stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $385.38, for a total transaction of $728,368.20. Following the completion of the transaction, the director owned 31,326 shares in the company, valued at approximately $12,072,413.88. This represents a 5.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mark Brazeal sold 25,000 shares of Broadcom stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $401.33, for a total value of $10,033,250.00. Following the completion of the sale, the insider directly owned 194,989 shares of the company’s stock, valued at approximately $78,254,935.37. This trade represents a 11.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 61,644 shares of company stock worth $24,016,214 over the last 90 days. 1.90% of the stock is owned by insiders.

Broadcom Profile (Free Report)

Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.

On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.

Featured Stories Five stocks we like better than Broadcom The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding AVGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Broadcom Inc. (NASDAQ:AVGO – Free Report).

Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.

The leading edge of 70 million baby boomers just started turning 80, and new senior housing construction sits at record lows. Three REITs are positioned to capture that collision, each through a structure that carries very different risk and income…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Senior housing and skilled nursing sit at the front end of a demographic wave that income investors near retirement are watching from personal experience: the leading edge of the nearly 70 million baby boomers has just begun turning 80 this year, while new construction starts remain at record lows. Ventas management framed the setup bluntly on its latest call: “there were a little over a thousand starts this quarter and there’s two million people turning 80 just in 2026 and that demographic demand wave continues for a decade.” All three names below are equity REITs (not mortgage REITs), and each captures the tailwind through a different structure.

Welltower: Scale Leader With SHOP Firing on All Cylinders Welltower (NYSE:WELL | WELL Price Prediction) is the largest senior housing landlord in the group, with a market cap of approximately $173.7 billion as of September 3, 2026. The portfolio spans Seniors Housing Operating (SHOP), Seniors Housing Triple-net, Outpatient Medical, and Long-Term/Post-Acute Care properties across the US, UK, and Canada. The SHOP structure matters for income investors: Welltower participates directly in facility operating results, not just rent collection, so occupancy and rate growth flow through to cash flow.

Q2 2026 was a record quarter. Normalized FFO came in at $1.60 per diluted share versus $0.65 consensus, revenue rose 40.9% YoY to $3.54 billion, SHOP same-store NOI grew 20.5% YoY, and SHOP same-store occupancy reached 89.4% (up from 86.1% YoY) with RevPOR growth of 5.2%. Management noted the 15th consecutive quarter in which NOI growth exceeded 20%, with operating margin expanding 300 basis points to over 32%, surpassing pre-COVID levels.

The quarterly dividend was raised to $0.85 per share (declared July 27, 2026, paid August 20, 2026), producing an annualized forward dividend of $3.40. Shares closed at $241.12 on September 3, 2026. Full-year 2026 Normalized FFO guidance was raised to $6.36 to $6.44 per diluted share. Measured on the right metric for REITs, FFO covers the $3.40 annualized dividend comfortably.

Bull case: Welltower is compounding cash flow off a scarce, needs-based asset class with pricing power. Approximately 96% of transactions were described as off-market, and management is layering in newer-vintage acquisitions at roughly 75% in-place occupancy at a circa 20% discount to replacement cost, leaving embedded lease-up upside.

One risk: Shares are up 31.27% year-to-date and 46.08% over the past year, so any operator hiccup, integration stumble on the C$4.1 billion Amica Senior Lifestyles acquisition, or FX turbulence in the UK/Canada books could compress the premium fast.

Ventas: SHOP Pivot With a Multi-Year Runway Ventas (NYSE:VTR) is a healthcare REIT focused on senior housing operating portfolio (SHOP), Outpatient Medical & Research (OM&R), and triple-net leased properties, with a market cap of approximately $47.2 billion as of September 3, 2026. Like Welltower, Ventas has been aggressively shifting its mix toward SHOP, where operator economics flow through directly. Management said on the Q2 call, “we are building shop to be 60% of our portfolio by the end of this year on a $60 billion enterprise.”

Q2 2026 delivered the fifth consecutive quarter beating analyst expectations. Normalized FFO reached $0.97 per share, up 9% YoY; SHOP Same-Store Cash NOI grew 16.3% YoY (US SHOP 18%); average occupancy rose 300 bps YoY (US SHOP 360 bps); RevPOR growth was 5%; and total company Same-Store Cash NOI grew 10.3%. The balance sheet firmed up too: Net Debt-to-Further Adjusted EBITDA improved to 4.7x from 5.6x YoY.

The quarterly dividend is $0.52 per share, with an annualized forward dividend of $2.08. Shares closed at $92.11 on September 3, 2026. Full-year 2026 Normalized FFO guidance was raised to $3.85 to $3.90 per share (8% to 10% YoY growth). Coverage on FFO, again the right metric here, is comfortable.

Bull case: CEO Debra Cafaro’s framing lays it out plainly: “Demographic demand is strong and getting stronger as the baby boomers begin turning 80 this year. Meanwhile, new supply remains at historic lows, setting up a compelling multiyear runway for growth and value creation.” Ventas has completed over $8 billion in investments since the beginning of 2024, adding more than 23,000 units across 174 communities to its SHOP portfolio, and its 2026 investment target was raised to $4.5 billion (from $3 billion), focused on senior housing.

One risk: The growth is being partly funded with equity. Ventas settled 31.4 million shares via forward sales for $2.6 billion year-to-date, and management said equitizing senior housing investments “I would expect that to continue.” Continued issuance can dilute per-share growth if deals underperform underwriting.

Omega Healthcare Investors: Skilled Nursing Cash Flow With a Coverage Lift Omega Healthcare Investors (NYSE:OHI) is the outlier of the three: a skilled nursing and senior housing REIT, primarily triple-net leased, expanding into RIDEA operating structures and international (UK/Canada), with a market cap of approximately $14.3 billion as of September 3, 2026. Triple-net means Omega collects contractual rent while operators bear staffing and expense volatility, a very different income profile from Welltower’s and Ventas’s SHOP-heavy books. That structure caps upside in an operator boom but insulates cash flow from labor-cost spikes.

AFFO was $0.83 per diluted share (up from $0.77 YoY); FAD per share was $0.78, up 5.4% YoY; revenue rose 16.2% YoY to $328.25 million; trailing 12-month EBITDAR coverage improved to 1.65x (from 1.55x YoY); and operator occupancy was stable at 82.6%. Omega executed a strategic sale of 18 CommuniCare facilities in MD and WV for $479.9 million gross proceeds, and transitioned the underperforming Laurels portfolio to stronger operators. On the call, Vikas Gupta said, “We really have no major concerns in our portfolios this time.”

The quarterly dividend was raised by a penny to $0.68 per share (declared July 23, 2026, paid August 14, 2026), producing an annualized forward dividend of $2.72. Shares closed at $47.04 on September 3, 2026. Full-year 2026 AFFO guidance was raised to $3.22 to $3.26 per diluted share, midpoint $3.24. Measured against AFFO (the appropriate coverage metric here), the $2.72 annualized dividend is covered.

Bull case: The skilled nursing operating backdrop is finally healing. CEO Taylor Pickett called it “the most favorable operating backdrop that I have known in my career,” and Megan Krull noted that “In June 2026, four years later, according to the Bureau of Labor Statistics, the industry finally recovered to those prior levels” after a 14% pandemic-era workforce loss. Combined with rising coverage and disciplined portfolio pruning, the setup supports the dividend.

One risk: Operator concentration and government reimbursement. Genesis Healthcare remains in Chapter 11 bankruptcy with $148.5 million in loans outstanding, and skilled nursing is heavily tied to Medicaid and Medicare. CMS set the 2026 skilled nursing facility daily coinsurance for days 21 through 100 at $217.00, up from $209.50 in 2025, a modest tailwind, but state Medicaid budgets remain the swing factor. Layer on the announced retirement of CEO Taylor Pickett after 25 years leading Omega, and there is transition risk to watch.

Bottom Line The three REITs offer distinct ways to own the same demographic wave. Welltower is the scale operator capturing the affluent-boomer trade with SHOP economics and margin leverage. Ventas is the pivot story, converting a healthcare REIT into a senior-housing-heavy growth vehicle. Omega is the yield play, taking triple-net rent from a healing skilled nursing industry with improving coverage and a covered payout. Income investors near retirement can build the exposure to fit the risk they want, from operating leverage at Welltower to contractual rent at Omega (the whole idea of living off the checks without touching the shares is the subject of our free dividend ladder guide, here), and the demand runway behind all three extends well into the next decade.

Contact [email protected] for any questions or corrections.

Ancora Advisors LLC reduced its holdings in Dell Technologies Inc. (NYSE:DELL – Free Report) by 64.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,002 shares of the technology company’s stock after selling 1,809 shares during the period. Ancora Advisors LLC’s holdings in Dell Technologies were worth $432,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Byrne Asset Management LLC acquired a new stake in Dell Technologies in the second quarter valued at $38,000. Atwood & Palmer Inc. raised its holdings in shares of Dell Technologies by 860.0% in the 2nd quarter. Atwood & Palmer Inc. now owns 96 shares of the technology company’s stock valued at $41,000 after purchasing an additional 86 shares during the period. Allied Private Wealth LLC acquired a new stake in Dell Technologies in the 2nd quarter valued at about $63,000. Elevation Wealth Partners LLC grew its holdings in Dell Technologies by 5,900.0% during the second quarter. Elevation Wealth Partners LLC now owns 180 shares of the technology company’s stock worth $78,000 after purchasing an additional 177 shares during the period. Finally, Commonwealth Retirement Investments LLC bought a new position in Dell Technologies during the fourth quarter worth about $25,000. 76.37% of the stock is owned by institutional investors.

Key Headlines Impacting Dell Technologies Here are the key news stories impacting Dell Technologies this week:

Positive Sentiment: Dell reported record quarterly revenue of approximately $46.97 billion, up nearly 58% year over year, while adjusted EPS of $7.04 exceeded the $4.91 consensus estimate. Dell shares gain after strong AI server demand boosts annual forecast Positive Sentiment: AI server orders reached a record $60.9 billion, helping expand Dell’s AI-related backlog to roughly $95 billion. The backlog provides significant revenue visibility and reinforces the view that AI capital spending is translating into hardware sales. Dell AI Server Momentum Accelerates With Record AI Orders Positive Sentiment: Management raised fiscal 2027 revenue guidance to approximately $192 billion from $167 billion and increased adjusted EPS guidance to $25.50 from $17.90. The higher outlook, Dell’s fifth consecutive revenue-guidance beat, prompted several analysts to lift price targets; JPMorgan raised its target to $635 while maintaining an Overweight rating. Dell shares rise as demand jumps for AI servers Positive Sentiment: Investors are increasingly viewing Dell as a key “picks-and-shovels” beneficiary of AI, particularly as enterprises consider on-premises infrastructure to control cloud-computing and AI token costs. Strong results from Broadcom and Hewlett Packard Enterprise have further supported the broader AI infrastructure trade. AI Infrastructure Demand Remains Red-Hot Wall Street Analysts Forecast Growth DELL has been the topic of several research analyst reports. Royal Bank Of Canada initiated coverage on Dell Technologies in a research note on Friday, May 29th. They issued an “outperform” rating on the stock. Loop Capital lifted their target price on Dell Technologies from $150.00 to $550.00 and gave the stock a “buy” rating in a research note on Friday, May 29th. Melius Research increased their price target on Dell Technologies from $650.00 to $735.00 and gave the company a “buy” rating in a research note on Wednesday. The Goldman Sachs Group raised their price target on Dell Technologies from $510.00 to $570.00 and gave the company a “buy” rating in a report on Wednesday. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Dell Technologies in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $553.79. Read Our Latest Stock Analysis on Dell Technologies

Insider Buying and Selling In related news, Director Silver Lake Partners Iv, L.P. sold 68,706 shares of the firm’s stock in a transaction on Thursday, July 9th. The stock was sold at an average price of $453.54, for a total value of $31,160,919.24. Following the transaction, the director owned 67,990 shares in the company, valued at approximately $30,836,184.60. This trade represents a 50.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Silver Lake Partners V. De (Aiv sold 34,869 shares of the company’s stock in a transaction dated Thursday, July 9th. The stock was sold at an average price of $453.54, for a total transaction of $15,814,486.26. Following the sale, the director directly owned 43,961 shares of the company’s stock, valued at $19,938,071.94. This represents a 44.23% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 1,527,629 shares of company stock valued at $619,325,485. 41.50% of the stock is currently owned by corporate insiders.

Dell Technologies Trading Up 4.2% NYSE:DELL opened at $512.66 on Friday. The stock has a 50 day simple moving average of $436.67 and a 200 day simple moving average of $307.41. The stock has a market cap of $332.26 billion, a P/E ratio of 29.75, a PEG ratio of 0.89 and a beta of 1.34. Dell Technologies Inc. has a 1-year low of $110.22 and a 1-year high of $530.78.

Dell Technologies (NYSE:DELL – Get Free Report) last announced its earnings results on Tuesday, September 1st. The technology company reported $7.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.91 by $2.13. The company had revenue of $46.97 billion during the quarter, compared to analysts’ expectations of $44.89 billion. Dell Technologies had a net margin of 7.53% and a negative return on equity of 578.85%. Dell Technologies’s quarterly revenue was up 57.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.70 earnings per share. Dell Technologies has set its FY 2027 guidance at 25.500-25.500 EPS and its Q3 2027 guidance at 6.500-6.500 EPS. As a group, sell-side analysts forecast that Dell Technologies Inc. will post 18.22 EPS for the current year.

Dell Technologies Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Tuesday, October 20th will be given a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Tuesday, October 20th. Dell Technologies’s payout ratio is presently 14.63%.

Dell Technologies Company Profile (Free Report)

Dell Technologies Inc is a multinational technology company that designs, manufactures and sells a broad range of information technology products, solutions and services. Its offerings span client computing devices (consumer and commercial laptops and desktops), enterprise infrastructure (servers, storage systems and networking equipment), software and cloud infrastructure, and a variety of professional services such as IT consulting, deployment, managed services and financing solutions. The company serves organizations of all sizes as well as individual consumers, with products and services aimed at enabling digital transformation and modern IT environments.

Founded by Michael Dell in 1984, the company grew from a direct-to-consumer PC business into a diversified IT provider through organic expansion and strategic acquisitions.

Featured Stories Five stocks we like better than Dell Technologies The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding DELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dell Technologies Inc. (NYSE:DELL – Free Report).

Receive News & Ratings for Dell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dell Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Jim Cramer called Campbell's snack quarter a nightmare and warned the whole category is broken, but two other packaged food giants reported something very different this week and raised their dividends to prove it.

Campbell’s (NASDAQ:CPB | CPB Price Prediction) declared a new quarterly dividend of $0.25 per share on September 3, 2026, down from the prior rate of $0.39 per share that had been paid across the preceding quarters. For income-focused shareholders, that is the headline. A dividend cut from a shelf-stable food company signals that management would rather retain cash to pay down debt than defend a payout it has grown comfortable with. Campbell’s said the reset is designed to accelerate debt reduction and strengthen the balance sheet.

Jim Cramer put it in less measured terms on his CNBC Mad Dash segment. His verdict on the quarter: “This is a nightmare. … This is a nightmare situation.” That framing is fair for Campbell’s but should not be taken as a verdict on packaged food in general.

Campbell’s: The Numbers Behind Cramer’s Verdict Campbell’s reported fiscal Q4 2026 with adjusted EPS of $0.39 on net sales of $2.14 billion, down 7.9% year over year. The GAAP line was a loss of $0.23 per share after $117 million in trademark impairment charges on Cape Cod and Kettle Brand and $75 million in restructuring. The 8-K filing shows the Snacks segment carried the pain: revenue of $950 million, organic sales down 6%, and segment operating earnings down 34%.

Cramer flagged the breadth of the damage: “The snack business is bad. The soup business is bad. I don’t even know what to say.” He added, “This is a brand that should have just gone away. And yet we all know it. We all know Campbell’s.” On the payout, Cramer confirmed the mechanical read: “Okay, it was a bad quarter and they’re slashing the dividend.” Cramer’s concern extended beyond one name. In the same segment he noted, “Tyson down six. They do cut the guide on this. Collapse in beef keeps coming back to beef.”

The price action confirms it. Campbell’s stock is down 20.6% year to date and 34.4% over one year, closing at $22.13. The Wall Street Journal reported the company is cutting 13% of its salaried workforce as part of the turnaround. Management has also outlined a $500 million enterprise cost savings program through FY2030 and guided FY2027 adjusted EPS to $1.65 to $1.80.

Mondelez: The Snack Story Cramer Did Not Tell Mondelez (NASDAQ:MDLZ) is the global pure-play snack company behind Oreo, Ritz, Milka, Cadbury, and Toblerone. Q2 2026 delivered adjusted EPS of $0.73 vs. $0.68 consensus on revenue of $9.36 billion, up 4.1%. Management raised FY2026 organic revenue growth guidance to at least 2% and hiked the dividend 4%. CEO Dirk Van de Put told investors emerging-market snacking is “a very structural situation. It’s not cyclical.”

Shares are up 14.2% year to date, ahead of the 13.2% gain in the S&P 500 ETF. One caveat: the one-year figure is just 0.2% higher. Cocoa costs remain a swing factor.

J.M. Smucker: The Strongest Legacy Food Name J.M. Smucker (NYSE:SJM) sells into the same American grocery aisles as Campbell’s, with Folgers, Dunkin’, Café Bustelo, Jif, Uncrustables, Smucker’s, Milk-Bone, and Hostess. Q1 FY2027 adjusted EPS was $3.24, compared with a $2.22 consensus, on revenue of $2.22 billion, aided by roughly $115 million in tariff refunds. Management raised FY2027 adjusted EPS guidance to $10.50 to $11.00 and lifted the quarterly dividend to $1.12.

The stock is up 31.4% year to date and 14.7% over one year, and it advanced 9.4% in the past month. The soft spot inside the portfolio is Sweet Baked Snacks (Hostess), where revenue fell 7% to $236.5 million, so the snack-weakness thesis has a landing spot even at a winning name.

Packaged Food Is Splitting, Not Sinking Organic sales strip out the effects of acquisitions, divestitures and currency, so the number reflects volume and price on the products a company actually still sells. On that basis, Campbell’s Snacks fell 6% while Mondelez raised its full-year organic revenue outlook. The category is being repriced downward for companies losing shelf momentum, and rewarded for those with pricing power, innovation, and coffee or global exposure. Uncrustables at Smucker and Oreo internationally do not care what happened to Kettle Brand.

For an income-focused investor who already owns a legacy shelf-brand name, the Campbell’s dividend reset is the signal that matters. Management confidence is now aimed at the balance sheet, not the payout. Campbell’s telegraphed most of the warning signs before the cut arrived (the same red flags we walked through in a free dividend trap guide). The category still has payers doing the opposite: Mondelez and Smucker each raised its dividend. The lesson from this week is to examine which company you hold, not to write off the entire category.

Contact [email protected] for any questions or corrections.

Docusign, the most trusted name in agreement tech, applies agreement engine to modern agentic enterprise tech stacks

, /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced it will open its Model Context Protocol (MCP) Server to every AI agent on September 30. With the Docusign MCP generally available globally, agreement intelligence and governed action — powered by AI engine Docusign Iris — are now callable natively from Claude, ChatGPT, Gemini, Copilot, Slack, and any MCP client, directly accessible by the agents running a business.

"For enterprise AI to truly succeed, it must integrate with the foundational systems that businesses rely on, like agreement management," said Allan Thygesen, CEO of Docusign. "Agents require a robust framework to analyze terms and execute end-to-end agreement workflows. Docusign becomes the essential agreement layer for any platform's agent, leveraging deep context and the rigorous governance customers demand. This is what evolves a connected agent into a trusted partner for contract management."

Docusign has operated an open, API-first platform for two decades, with eSignature embedded in over 1,100 partner-built applications. Now, Docusign's MCP Server extends that same open architecture for agents leveraging a full intelligent agreement suite. The Docusign MCP Server is built for the enterprise, with account-level admin controls, global multi-region infrastructure, and multilingual support. Agents will draw on the full context of past negotiations, accepted terms, clauses, and company policy through Iris, Docusign's AI engine, across Intelligent Agreement Management, and even in advanced CLM workflows.

Available everywhere work happens

Docusign eliminates the need for app-switching that slows deals down by natively embedding contract analysis, sending, and tracking where work already happens. This runs bidirectionally with data from systems like Oracle flowing directly into Docusign, while Docusign's own capabilities extend outward into Slack, Perplexity, and Salesforce where Iris runs natively alongside Agentforce. Salesforce recently named Docusign as a Partner of the Year award winner, recognizing IAM integrations across Salesforce, Agentforce and Slack that empower customers to close deals, pull contract insight for renewals and collaborate on agreements without leaving their flow of work.

Here's what beta customers and partners had to share:

"Salesforce delivers AI agents you can trust, serving customers 24/7, generating new pipeline, and handling routine work at scale — so people can focus on judgment, relationships, and growth. Collaborating with Docusign adds real value for customers who are building their Agentic Enterprise with Salesforce. Agentforce and Slackbot will read and act on contract terms in real-time to accelerate high value sales and service actions. Together we accelerate business processes that our customers really care about," said Joe Inzerillo, President Enterprise & AI Technology, Salesforce. "As organizations move from AI experimentation to enterprise-scale deployment, agreements are an essential workflow that agents need to understand and act on securely. Docusign's MCP capabilities give organizations a practical way to bring agreement workflows into the AI platforms and agent experiences where employees already work. Slalom looks forward to helping joint customers design and deploy these connected experiences in a way that drives productivity while supporting the governance, integration, and change management required for enterprise adoption," said Carlos Etter, Director of Global Enterprise Applications & CLM Practice Leader, Slalom. "Docusign is Experian's core agreement layer. As an early enterprise customer, we're exploring how agentic capabilities can strengthen our agreement intelligence — verifying accuracy at the drafting stage, automating across the contract lifecycle, and in doing so improving both how our teams work and how our clients experience contracting with us. We're excited by the potential agents hold for how enterprises manage agreements at scale," said Gary Sonnenthal, VP, Global Quote to Cash Product Owner, Experian. About Docusign

Docusign brings agreements to life. Over 1.9 million customers and more than a billion people in over 180 countries use Docusign solutions to accelerate the process of doing business and simplify people's lives. With intelligent agreement management, Docusign unleashes business critical data that is trapped inside of documents. Until now, these were disconnected from business systems of record, costing businesses time, money, and opportunity. Using Docusign's AInative IAM platform, companies can create, commit, and manage agreements with solutions created by the #1 company in e-signature and CLM. Learn more at www.docusign.com.

Media Contact:
Docusign Communications
[email protected] 

SOURCE Docusign, Inc.

B. Metzler seel. Sohn & Co. AG increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 69.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,192 shares of the financial services provider’s stock after purchasing an additional 14,418 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in CME Group were worth $7,771,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. BlackRock Inc. purchased a new stake in shares of CME Group in the second quarter valued at about $6,749,965,000. Norges Bank acquired a new position in CME Group in the 4th quarter valued at about $1,523,241,000. Bank of New York Mellon Corp purchased a new stake in CME Group during the 2nd quarter valued at approximately $867,313,000. Alphabet Inc. purchased a new stake in CME Group during the 2nd quarter valued at approximately $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in CME Group during the 2nd quarter worth approximately $629,771,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity In other CME Group news, Director William Shepard acquired 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth Several research analysts have weighed in on CME shares. Morgan Stanley lifted their target price on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Bank of America upped their price target on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. The Goldman Sachs Group lowered their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Raymond James Financial reissued an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Finally, Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $289.75. View Our Latest Report on CME

CME Group Stock Performance CME opened at $282.05 on Friday. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The stock has a market cap of $101.42 billion, a P/E ratio of 23.92, a P/E/G ratio of 3.28 and a beta of 0.24. The stock’s 50 day simple moving average is $257.55 and its 200 day simple moving average is $278.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group’s revenue was up .8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.96 earnings per share. As a group, equities analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

About CME Group (Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also Five stocks we like better than CME Group The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

$52.76

+3.72%

Software company Dynatrace, Inc. (DT) up 22% in 2026 thanks to institutional inflows.

In this article:DT

+3.72%

DT offers an AI-enabled technology platform that monitors enterprise cloud environments across geographical regions to optimize application performance and security. The company’s first-quarter 2027 report showed $2.14 billion in annual recurring revenue (a 17% year-over-year gain), total revenue of $554.5 million (a 15% jump), non-GAAP net income of $0.48 per share (exceeding guidance of $0.03 per share), and offered second-quarter revenue and full-year non-GAAP operating margin guidance of up to $570 million and 29.75%, respectively.

It’s no wonder DT shares are up 22% this year – and they could rise more. MoneyFlows data shows how Big Money investors are once again betting heavily on the forward picture of the stock.

Institutions Back for Dynatrace Institutional volumes reveal plenty. So far in 2026, DT has enjoyed strong investor demand, which we believe to be institutional support.

Each green bar signals unusually large volumes in DT shares. They reflect our proprietary inflow signal, pushing the stock higher:

Institutional inflows are again boosting DT shares, with inflows beginning in June helping send shares up 22% so far in 2026. Source: www.moneyflows.com Plenty of technology names are under accumulation right now. But there’s a powerful fundamental story happening with Dynatrace.

Dynatrace Fundamental Analysis Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, DT has had strong sales and earnings growth:

3-year sales growth rate (+20.3%) 3-year EPS growth rate (+60.6%) Source: FactSet

Also, EPS is estimated to ramp higher this year by +14.6%.

Now it makes sense why the stock has been generating Big Money interest again. DT has a track record of strong financial performance.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long term.

Dynatrace has been a top-rated stock at MoneyFlows. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Outlier 20 report twice this year and 29 times since 2015. The blue bars below show when DT was a top pick in 2026…institutions remain buyers:

Two outlier inflows kept DT shares gaining – there have been 29 total outlier signals since 2015. Source: www.moneyflows.com Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward.

Dynatrace Price Prediction The DT revival isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no position in DT at the time of publication.

If you are a Registered Investment Advisor (RIA) or a serious investor, take your investing to the next level. MoneyFlows created 11 Frontiers indexes to help serious investors capture AI-driven themes and learn the leading stocks in each Frontier. Get started here.

Related Articles

Earnings Beat, Raised Guidance Send Paycom Shares HigherS&P500 and Nasdaq 100: Payrolls Will Decide if Waller’s Rally Gets Follow-ThroughUS Jobs Report Puts Yields, XLE, Copper and CAC 40 in FocusAbout the Author

Lucas is a well-versed equity investor and educator. He currently is co-founder of research and analytics firm, MAPsignals.com, which focuses on finding outlier stocks by following the Big Money.

Latest news and analysis